gujarat technological university student list for …...pragnesh patani 206 26-nov-18 172080820001...

Date MAP_NUMBER Student_name sub codeBranch_

Code

College_

Code

Branch_T

ypeBranch_name Micro Other_Micro DP1_TITLE Guide Name

Guide

Code

26-Nov-18 172060820001 Gokani Preet Nitinkumar MRW304P 20 206 MP Pharmaceutics MISCELANEOUSFORMULATION DEVELOPMENT AND EVALUATION OF

ACECLOFENAC LOADED EMULGELDR. MITTAL MAHESHWARI 206

26-Nov-18 172060820002 MALAVIYA VIKASKUMAR MADHUBHAI MRW304P 20 206 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION DEVELOPMENT AND EVALUATION OF

ONDANSETRON HCL EXTENDED RELEASE TABLETDR. MITTAL MAHESHWARI 206

26-Nov-18 172060820003 Swati Adhikari MRW304P 20 206 MP Pharmaceutics MISCELANEOUSEVALUATION OF HOLD TIME ON DRUG PRODUCT WITH

RESPECT TO PHYSICAL PARAMETERSDR. MITTAL MAHESHWARI 206

26-Nov-18 172060824001 CHAUHAN SUDIKSHA RAMKUMAR MRW304P 24 206 MPPharmaceutical Quality

AssuranceSTABILITY STUDIES

A RAPID STABILITY INDICATING RP-UPLC METHOD

DEVELOPEMENT AND VALIDATION FOR ASPIRIN,

ROSUVASTATIN CALCIUM AND CLOPIDOGREL BISULPHATE IN

TABLET DOSAGE FORM

DR. NEHA TIWARI 206

26-Nov-18 172060824002 Dodiya Karan sinh Vajesangbhai MRW304P 24 206 MPPharmaceutical Quality


METHOD DEVELOPMENT AND VALIDATION OF STABILITY

INDICATING OF DIAZEPAM AND DICYCLOMINE IN TABLET

DOSAGE FORM

DR. PRAGNESH PATANI 206

26-Nov-18 172060824003 GUPTA MONIKA HARERAM MRW304P 24 206 MPPharmaceutical Quality


METHOD DEVELOPEMENT AND VALIDATION OF STABILITY

INDICATING RP-HPLC METHOD FOR ACEBROFYLLINE AND

DOXOFYLLINE IN TABLET DOSAGE FORM

DR.PRAGNESH PATANI 206

26-Nov-18 172060824004 MUDALIAR REVATI GANESHBHAI MRW304P 24 206 MPPharmaceutical Quality


DEVELOPMENT AND VALIDATION OF STABILITY INDICATING

RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF

ATORVASTATIN AND EZETIMIBE IN TABLET DOSAGE FORM


26-Nov-18 172060824005 PATEL BHARGAVKUMAR PRADIPBHAI MRW304P 24 206 MPPharmaceutical Quality

AssuranceSIMULTENEOUS ESTIMATION

ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF

THE SIMULTANEOUS ESTIMATION OF

TRIHEXYPHENIDYL,TRIFLUOPERAZINE AND THIORIDAZINE IN

ITS PHARMACEUTICAL DOSAGE FORM BY HPLC METHOD

MRS.VANITA MARVANIYA 206

26-Nov-18 172060824006 PATEL DIPALIBEN JAYANTIBHAI MRW304P 24 206 MPPharmaceutical Quality


STABILITY INDICATING RP-UPLC METHOD DEVELOPEMENT

AND VALIDATION FOR OLMESARTAN MEDOXOMIL,

CHLORTHALIDONE AND CLINIDIPINE IN THEIR COMBINED

TABLET DOSAGE FORM

DR. NEHA TIWARI 206

26-Nov-18 172060824007 PATEL YASH KANUBHAI MRW304P 24 206 MPPharmaceutical Quality

AssuranceBIOANALYTICAL

BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION

FOR ESTIMATION OF FORMOTEROL IN HUMAN PLASMA BY LC-

MS/MS.


26-Nov-18 172060824009 SURANI RONAKKUMAR SURESHBHAI MRW304P 24 206 MPPharmaceutical Quality


STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND

VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF

TICLOPIDINE AND ASPIRIN IN ITS PHARMACEUTICAL DOSAGE

FORM


26-Nov-18 172060824011 VAGHELA AKSHAY PRAVINBHAI MRW304P 24 206 MPPharmaceutical Quality


STABILITY INDICATING HPLC METHOD DEVELOPMENT AND

VALIDATION FOR SIMULTANEOUS DETERMINATION OF

IBUPROFEN AND HYDROCODONE BITARTRATE IN THEIR

COMBINED DOSAGE FORM

DR. NEHA TIWARI 206

26-Nov-18 172060824012 VAGHELA YAVANTIKA VIRENDRASINH MRW304P 24 206 MPPharmaceutical Quality



ASSAY METHOD FOR ESTIMATION OF DESVENLAFAXINE IN

EXTENDED RELEASE TABLET DOSAGE FORM


26-Nov-18 172080820001 BHATT VIBHUTI DHIRENKUMAR MRW304P 20 208 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST

DISPERSIBLE/DISSOLVISTUDY ON DISSOLUTION ENHANCEMENT OF EZETIMIBE DR. DASHRATH PATEL 208

26-Nov-18 172080820002 DHRU KHUSHALI DARSHAKBHAI MRW304P 20 208 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,

TOPICAL, HYDROGELS NASAL

FORMULATION AND EVALUATION OF INTRANASAL DRUG

DELIVERY OF DIAZEPAM FOR STATUS EPILEPTICUS.DR. DASHRATH PATEL 208

26-Nov-18 172080820003 PATEL DHRUV JAYNESHKUMAR MRW304P 20 208 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF FIXED DOSE GASTRO-

RETENTIVE BILAYER TABLET CONTAINING METFORMIN AS

SUSTAINED RELEASE AND SIMVASTATIN AS IMMEDIATE

RELEASE.

DR. UPENDRA L PATEL 208

26-Nov-18 172080820004 RUPARELIYA KETA SHAILESHBHAI MRW304P 20 208 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


NASAL INSITU GEL OF ANTI-HIV DRUG FOR NOSE TO BRAIN

DRUG DELIVERY.DR. SUNITA CHAUDHARY 208

26-Nov-18 172080824001 PANCHAL URVISHA GOVINDBHAI MRW304P 24 208 MPPharmaceutical Quality


STABILITY INDICATING HPTLC METHOD DEVELOPMENT AND

VALIDATION OF DACLATASVIR DIHYDROCHLORIDE IN

PHARMACEUTICAL DOSAGE FORM

DR. RAGIN SHAH 208

Gujarat Technological University

Student list for M.Pharm Sem 3 (Regular) Dissertation Phase-1 Exam (Winter 2018)GTU/W18/DP-1/MPH-2926/8425 Date:- 16/11/2018

26-Nov-18 172080824002 PARMAR MONIKA JAGDISHBHAI MRW304P 24 208 MPPharmaceutical Quality


STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT &

VALIDATION OF S(-) AMLODIPINE AND HYDROCHLORTHIAZIDE

IN BULK AND PHARMACEUTICAL DOSAGE FORM

MR HIREN KADIKAR 208

26-Nov-18 172080824003 PATEL BHOOMIKA VINODBHAI MRW304P 24 208 MPPharmaceutical Quality



VALIDATION OF DOLUTRGRAVIR, LAMIVUDIN, TENOFOVIR

DISOPROXIL FUMARATE IN PHARMACEUTICAL DOSAGE FORM

MS MONA KAUSHAL 208

26-Nov-18 172080824004 PATEL NIDHIBEN VINODBHAI MRW304P 24 208 MPPharmaceutical Quality



VALIDATION OF DOFETILIDE IN CAPSULE DOSAGE FORMDR NISHA PARIKH 208

26-Nov-18 172080824005 SAIYAD ANISH MIRSHABMIYA MRW304P 24 208 MPPharmaceutical Quality


STABILITY INDICATING METHOD DEVELOPMENT AND

VALIDATION FOR SIMULTANEOUS ESTIMATION OF

EMTRICITABINE AND TENOFOVIR ALAFENAMIDE IN TABLET

DOSAGE FORM

DR JITENDRA PATEL 208

26-Nov-18 172080824006 SHAH CHARMI RAJESH MRW304P 24 208 MPPharmaceutical Quality



VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF

ILAPRAZOLE AND LEVOSULPRIDE IN PHARMACEUTICAL

DOSAGE FORM

MS JIGNASHA DERASARI 208

26-Nov-18 172240824001 CHAUDHARY RAJESHBHAI BHIKHABHAI MRW304P 24 224 MPPharmaceutical Quality




SERTACONAZOLE AND BECLOMETHASONE IN ITS


DR. HIRAL PANCHAL 224

26-Nov-18 172240824002 DAMSIYA NIKHIL KARSHANBHAI MRW304P 24 224 MPPharmaceutical Quality




BENIDIPINE HYDROCHLORIDE AND CHLORTHALIDONE IN ITS


DR. HIRAL PANCHAL 224

26-Nov-18 172280820001 BHAVSAR JAINI PANKAJKUMAR MRW304P 20 228 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION, DEVELOPMENT AND EVALUATION OF

CONTROLLED RELEASE TABLET OF ANTIDIABETIC AGENT.DR. YAMINI SHAH 228

26-Nov-18 172280820002 DESHMUKH GAURI NITEEN MRW304P 20 228 MP Pharmaceutics OTHER (KINDLY SPECIFY)FORMULATION, DEVELOPMENT AND EVALUATION OF SOLID

ORAL DOSAGE FORM OF PAROXETINE MESYLATEDR. PRAFUL BHARADIA 228

26-Nov-18 172280820003 JAHNAVI BHARGAV JANI MRW304P 20 228 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,



TOPICAL PREPARATION OF LUTEIN DR. PRAFUL BHARADIA 228

26-Nov-18 172280820004 MANAN VISHNUBHAI PATEL MRW304P 20 228 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION AND DEVELOPMENT OF ORAL

TRANSMUCOSAL DELIVERY SYSTEM OF AN ANTI-MIGRAINE

AGENT

DR. RADHIKA PANDYA 228

26-Nov-18 172280820005 NAMIT GUPTA MRW304P 20 228 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST

DISPERSIBLE/DISSOLVI

MOUTH DISSOLVING FILMS OF NARATRIPTAN

HYDROCHLORIDEDR. MANISH P. PATEL 228

26-Nov-18 172280820006 PATEL GRUSHA SANJAYKUMAR MRW304P 20 228 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,



SPIRONOLECTONE GEL FOR TREATMENT OF ANDROGENIC

ALOPECIA

DR. PRAFUL BHARADIA 228

26-Nov-18 172280820007 Patel Het Suryakantbhai MRW304P 20 228 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION, DEVELOPMENT AND EVALUATION OF ORAL

DOSAGE FORM OF AN ANTI-OSTEOPOROTIC AGENTDR. PRAFUL BHARADIA 228

26-Nov-18 172280820008 ROMANSHA ANIL BERI MRW304P 20 228 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST



SUBLINGUAL TABLETS OF AN ANTI-PSYCHOTIC DRUGDR. YAMINI SHAH 228

26-Nov-18 172280820009 Shah Pahini Jigarbhai MRW304P 20 228 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION, OPTIMIZATION AND EVALUATION OF

CONTROLLED RELEASE TABLETS OF LORCASERIN

HYDROCHLORIDE

DR. MANISH P. PATEL 228

26-Nov-18 172280820010 SOLANKI SNEHABEN BALDEVBHAI MRW304P 20 228 MP Pharmaceutics OTHER (KINDLY SPECIFY)PAEDIATRIC FORMULATION OF CEFIXIME TRIHYDRATE AND

ITS EVALUATIONDR. YAMINI SHAH 228

26-Nov-18 172280824001 CHAUHAN KEYURKUMAR RAMESHBHAI MRW304P 24 228 MPPharmaceutical Quality


DEVELOPMENT AND VALIDATION OF UV

SPECTROPHOTOMETRIC AND CHROMATOGRAPHIC METHODS

FOR SIMULTANEOUS ESTIMATION OF BENIDIPINE

HYDROCHLORIDE AND TELMISARTAN IN THEIR COMBINED

DOSAGE FORM

DR. KUNJAN BODIWALA 228

26-Nov-18 172280824004 MODI PINAL SATISHKUMAR MRW304P 24 228 MPPharmaceutical Quality


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD

FOR SIMULTANEOUS ESTIMATION OF NEBIVOLOL

HYDROCHLORIDE AND TELMISARTAN IN THEIR COMBINED

DOSAGE FORM

DR. SINDHU EZHAVA 228

26-Nov-18 172280824005 Patel Nidhi Tikendrabhai MRW304P 24 228 MPPharmaceutical Quality


DEVELOPMENT AND VALIDATION OF CHROMATOGRAPHIC

METHOD FOR SIMULTANEOUS ESTIMATION OF OFLOXACIN,

TINIDAZOLE, TERBINAFINE HYDROCHLORIDE AND

CLOBETASOL PROPIONATE IN TOPICAL FORMULATION


26-Nov-18 172280824008 SHARMA PRIYANKA KAMLESHBHAI MRW304P 24 228 MPPharmaceutical Quality


DEVELOPMENT AND VALIDATION OF A STABILITY FOR

INDICATING HPTLC METHOD FOR TENELIGLIPTIN AND

METFORMIN.

DR. MAHESH T. CHHABRIA 228

26-Nov-18 172420820001 GOSWAMI ASAV NARENDRAPURI MRW304P 20 242 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


PHYSICOCHEMICAL CHARACTERIZATION AND IN-VITRO

DISSOLUTION ENHANCEMENT OF RANOLAZINE USING SOLID

DISPERSION METHOD

DR S.K.SHAH 242

26-Nov-18 172420820002 Parekh Aarti Jayprakash MRW304P 20 242 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DEVELOPMENT & EVALUATION OF GASTRO RETENTIVE

FLOATING TABLETS FOR ORAL DRUG DELIVERY OF

ENTACOPONE

DR DHAVAL J PATEL 242

26-Nov-18 172420820004 Patel Parth Laxmanbhai MRW304P 20 242 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF GASTRIC ORAL

FLOATING TABLETS CONTAINING CAPTOPRIL AND

HYDROCHLOROTHIAZIDE

DR S.K.SHAH 242

26-Nov-18 172420820005 PATEL PRIYANK MUKESHBHAI MRW304P 20 242 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND IN-VITRO DISSOLUTION ENHANCEMENT

OF BLONANSERIN USING LIQUISOLID COMPACTSDR SANJESH G RATHI 242

26-Nov-18 172420820007 SHAH JIGAR PRADIPKUMAR MRW304P 20 242 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU


FLOATING TABLETS OF APREMILASTDR DHAVAL J.PATEL 242

26-Nov-18 172420824005 SUDHIRKUMAR GAMI MRW304P 24 242 MPPharmaceutical Quality


RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR

SIMULTANEOUS ESTIMATION OF BENIDIPINE

HYDROCHLORIDE, TELMISARTAN AND CHLORTHALIDONE IN

TABLET

DR. ANKIT B. CHAUDHARY 242

26-Nov-18 172420824006 SUTHAR NISHABEN JAYESHKUMAR MRW304P 24 242 MPPharmaceutical Quality


RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR

SIMULTANEOUS ESTIMATION OF ORLISTAT AND

RESVERATROL IN CAPSULE

MS. CHARMY D. PANDYA 242

26-Nov-18 172600820001 ANKIT SINGH KUSHWAH MRW304P 20 260 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DEVELOPMENT, OPTIMIZATION AND EVALUATION OF

EXTENDED RELEASE TABLET OF PALIPERIDONEDR. KUNAL N. PATEL 260

26-Nov-18 172600820004 PATEL KRUSHIKA JAGDISHKUMAR MRW304P 20 260 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF MOUTH DISSOLVING

FILM OF FEXOFENADINE HYDROCHLORIDEDR. KUNAL N. PATEL 260

26-Nov-18 172600824001 BAMBHROLIYA VIREN GHANSHYAMBHAI MRW304P 24 260 MPPharmaceutical Quality



FOR ESTIMATION OF FLUTICASONE IN HUMAN PLASMA BY LC-

MS/MS

DR. CHIRAG J. PATEL 260

26-Nov-18 172600824002 KIRAD AASHUTOSHSINH RAMNATH MRW304P 24 260 MPPharmaceutical Quality


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR

SIMULTANEOUS ESTIMATION OF ATORVASTATIN AND

SITAGLIPTIN PHOSPHATE IN SYNTHETIC MIXTURE

MS. MITALI JASANI 260

26-Nov-18 172600824004 PANCHAL SHIVANI HITESHKUMAR MRW304P 24 260 MPPharmaceutical Quality



ASSAY METHOD FOR ESTIMATION OF TOFACITINIB IN

TOFACITINIB CITRATE IMMEDIATE RELEASE TABLET DOSAGE

FORM


26-Nov-18 172600824006 PATEL DIMPLE NATVARLAL MRW304P 24 260 MPPharmaceutical Quality


METHOD DEVELOPMENT AND VALIDATION BY

CHROMATOGRAPHIC METHOD FOR DETERMINATION OF

ERYTHROMYCIN IN PHARMACEUTICAL DOSAGE FORM


26-Nov-18 172620820001 BACHANI KOMAL KANAIYALAL MRW304P 20 262 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION AND EVALUATION OF TRANSDERMAL

PATCHES OF ADEFOVIR DIPIVOXIL FOR THE TREATMENT OF

HEPATITIS B

PROF. BHUMI RAVAL 262

26-Nov-18 172620820002 PARMAR MADHAVSINH VIJAYBHAI MRW304P 20 262 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND CHARACTERIZATION OF MOUTH

DISSOLVING TABLETS OF VILAZODONE HCL FOR THE

TREATMENT OF DEPRESSION

PROF. RAVI V. PATEL 262

26-Nov-18 172620820004 PRAJAPATI RINKUBEN ASHOKBHAI MRW304P 20 262 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND OPTIMIZATION OF SWELLING TABLETS

OF SOFOSBUVIR FOR THE TREATMENT OF HEPATITIS CPROF. BHUMI RAVAL 262

26-Nov-18 172620820005 SHAH AMIBEN MAHESHKUMAR MRW304P 20 262 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND CHARACTERIZATION OF FAST

DISSOLVING TABLETS OF LINAGLIPTIN- AN ANTI-DIABETIC

AGENT

PROF. SURAJ R. CHAUHAN 262

26-Nov-18 172620820006 SHUKLA ABHAYKUMAR SANTOSH MRW304P 20 262 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND OPTIMIZATION OF ORAL

DISINTEGRATING STRIPS OF TENELIGLIPTIN FOR THE

TREATMENT OF TYPE II DIABETES

PROF. RAVI V. PATEL 262

26-Nov-18 172620824001 BASITA NIKHIL CHAMPAKBHAI MRW304P 24 262 MPPharmaceutical Quality



SIMULTANEOUS ESTIMATION OF PIOGLITAZONE

HYDROCHLORIDE AND VILDAGLIPTIN IN SYNTHETIC MIXTURE

DR. JITENDRA O. BHANGALE 262

26-Nov-18 172620824002 DAVE MANSIBEN SHIRISHKUMAR MRW304P 24 262 MPPharmaceutical Quality



SIMULTANEOUS ESTIMATION OF LOSARTAN POTASSIUM AND

ROSUVASTATIN CALCIUM IN SYNTHETIC MIXTURE


26-Nov-18 172620824003 HIMANI RAJESHKUMAR SAVANI MRW304P 24 262 MPPharmaceutical Quality



SIMULTANEOUS ESTIMATION OF SIMVASTATIN AND

PIOGLITAZONE HYDROCHLORIDE IN SYNTHETIC MIXTURE


26-Nov-18 172620824004 MOURYA POONAM GHANSHYAMBHAI MRW304P 24 262 MPPharmaceutical Quality



SIMULTANEOUS ESTIMATION OF LISINOPRIL AND LOSARTAN

POTASSIUM IN SYNTHETIC MIXTURE


26-Nov-18 172620824005 PARTH SHAKARABHAI PATEL MRW304P 24 262 MPPharmaceutical Quality



SIMULTANEOUS ESTIMATION OF PIOGLITAZONE

HYDROCHLORIDE AND NATEGLINIDE IN SYNTHETIC MIXTURE


26-Nov-18 172620824006 PATEL BINAL NARESHBHAI MRW304P 24 262 MPPharmaceutical Quality

AssuranceIMPURITY PROFILING


IMPURITY PROFILE OF CITICOLINE SODIUM IN TABLET

DOSAGE FORM


26-Nov-18 172620824008 PATEL DIVYABEN VIRCHANDBHAI MRW304P 24 262 MPPharmaceutical Quality


METHOD DEVELOPMENT AND VALIDATION OF LEVODOPA

AND BENSERAZIDE IN ORAL DISPERSIBLE TABLET BY RP-HPLC

METHOD

DR JITENDRA O. BHANGALE 262

26-Nov-18 172620824009 PATEL HIRAL ASHOKBHAI MRW304P 24 262 MPPharmaceutical Quality



SIMULTANEOUS ESTIMATION OF RAMIPRIL AND

SIMVASTATIN IN SYNTHETIC MIXTURE


26-Nov-18 172620824010 Saini Ravi bhanwarlal MRW304P 24 262 MPPharmaceutical Quality



SIMULTANEOUS ESTIMATION OF VILDAGLIPTIN AND

NATEGLINIDE IN SYNTHETIC MIXTURE

DR JITENDRA O. BHANGALE 262

26-Nov-18 172620824011 SONARA KAJAL HARIBHAI MRW304P 24 262 MPPharmaceutical Quality



SIMULTANEOUS ESTIMATION OF REPAGLINIDE AND

SITAGLIPTIN PHOSPHATE IN SYNTHETIC MIXTURE


26-Nov-18 172620824012 TRIVEDI FORAM DHARMENDRABHAI MRW304P 24 262 MPPharmaceutical Quality



SIMULTANEOUS ESTIMATION OF NEBIVOLOL

HYDROCHLORIDE AND LISINOPRIL IN SYNTHETIC MIXTURE


26-Nov-18 172860824001 kunal Bhatt MRW304P 24 286 MPPharmaceutical Quality


DEVELOPMENT AND VALIDATION OF BIOANALYTICAL

METHOD FOR DETERMINATION OF CLOMIPRAMINE FROM K3

EDTA HUMAN PLASMA USING LC-MS/MS.

DR. MANDEV B. PATEL 286

26-Nov-18 172860824002 Kuntalkumar maheshbhai prajapati MRW304P 24 286 MPPharmaceutical Quality



METHOD FOR DETERMINATION OF AMBRISENTAN FROM K3

EDTA HUMAN PLASMA USING LC-MS/MS.


26-Nov-18 172860824003 MAKWANA HEMANGIBEN SHASHIKANT MRW304P 24 286 MPPharmaceutical Quality



RP HPLC METHOD FOR DETERMINATION OF EFONIDIPINE IN

BULK AND TABLET DOSAGE FORM.

MRS. BINNY D. MEHTA 286

26-Nov-18 172860824007 Prajapati Kinnari Dasharathbhai MRW304P 24 286 MPPharmaceutical Quality



MEHTHOD FOR DETERMINATION OF DEFERASIROX FROM

HUMAN PLASMA USING LC-MS/MS.

MS. MINAKSHI DHORU 286

26-Nov-18 172860824008 sangale Hemangi Shivji MRW304P 24 286 MPPharmaceutical Quality



RP HPLC METHOD FOR DETERMINATION OF MIRABEGRON

FROM ITS PHARMACEUTICAL FORMULATION

MRS. BINNY D. MEHTA 286

26-Nov-18 172860824009 Shah Kajal Rajendrabhai MRW304P 24 286 MPPharmaceutical Quality



METHOD FOR DETERMINATION OF EXEMESTANE FROM K3

EDTA HUMAN PLASMA USING LC-MS/MS

MS. MINAKSHI DHORU 286

26-Nov-18 172860824014 vikas pal MRW304P 24 286 MPPharmaceutical Quality



METHOD FOR DETERMINATION OF PROPAFENONE FROM K3

EDTA HUMAN PLASMA USING LC-MS/MS


27-Nov-18 172060824010 Vadaliya Zaranaben kantibhai MRW304P 24 206 MPPharmaceutical Quality

AssuranceREGULATORY AFFAIRS

QUANTITATIVE COMPARISON BETWEEN ACTIVE MEDICINAL

CONSTITUENTS OF SOME COMMONLY PRESCRIBED BRANDED

AND GENERIC DRUGS


27-Nov-18 172070820001 MANSURI AKIBBHAI YASINBHAI MRW304P 20 207 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DEVELOPMENT AND CHARACTERIZATION OF CONTROLLED

RELEASE MATRIX TABLET OF TIAGABINE HYDROCHLORIDE

DR. ANANDKUMAR

KANAIYALAL PATEL207

27-Nov-18 172070820002 PANDYA KHYATIBEN NITINKUMAR MRW304P 20 207 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


“FORMULATION AND EVALUTION OF BILAYERED BUCCAL

TABLET OF IVABRADINE HYDROCHLORIDE”DR. VISHNU M. PATEL 207

27-Nov-18 172070820003 patel yaminibahen nikhilkumar MRW304P 20 207 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


“FORMULATION AND EVALUTION OF BUCCAL PATCH

CONTAINING DULOXETINE HYDROCHLORIDE FOR THE

TREATMENT OF DEPRESSION’’

DR. VISHNU M. PATEL 207

27-Nov-18 172070820004 SHAH MONIKA NIKILKUMAR MRW304P 20 207 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


PREPARATION AND EVALUATION OF SUBLINGUAL TABLET OF

HYDRALAZINE HYDROCHLORIDE

DR. ANANDKUMAR

KANAIYALAL PATEL207

27-Nov-18 172070820005 Vadaliwala Munavvarbanu Abdullatif MRW304P 20 207 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


DEVELOPMENT AND EVALUATION OF ORODISPERSIBLE

TABLET OF APIXABAN

DR. ANANDKUMAR

KANAIYALAL PATEL207

27-Nov-18 172250820001 ANKULGE SUNIL BABURAO MRW304P 20 225 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF SUBLINGUAL TABLETS

OF BUSPIRONE HYDROCHLORIDEDR. SHAILESH T. PRAJAPATI 225

27-Nov-18 172250820002 KANSAGARA AMEEBEN RAMNIKBHAI MRW304P 20 225 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF COLON TARGETED

TABLETS OF ELUXADOLINEDR. SHAILESH T. PRAJAPATI 225

27-Nov-18 172250820003 Patel Bhaveshkumar Amrutlal MRW304P 20 225 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION AND EVALUATION OF BUCCAL FILMS OF

PIRIBEDILDR. SHAILESH T. PRAJAPATI 225

27-Nov-18 172250820004 PATEL JASMINABAHEN VISHNUBHAI MRW304P 20 225 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF SUSTAINED RELEASE

MATRIX TABLETS OF NATEGLINIDEDR. SHAILESH T. PRAJAPATI 225

27-Nov-18 172250820005 PATEL NILESHKUMAR MUKESHBHAI MRW304P 20 225 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF GASTRORETENTIVE

MUCOADHESIVE TABLETS OF RANOLAZINEDR. KEYUR S. PATEL 225

27-Nov-18 172250820006 PATEL RAJAT BHARATBHAI MRW304P 20 225 MP Pharmaceutics MULTIPARTICULATEFORMULATION AND EVALUATION OF SUSTAINED RELEASE

MICROSPHERES OF ITOPRIDE HYDROCHLORIDE DR. KEYUR S. PATEL 225

27-Nov-18 172250820007 PATEL SUMIT RAJESHBHAI MRW304P 20 225 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF FLOATING TABLETS OF

PROPAFENONE HYDROCHLORIDEDR. KEYUR S. PATEL 225

27-Nov-18 172250820008 PATEL VRUNDABEN CHHGANBHAI MRW304P 20 225 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF SUBLINGUAL FILM OF

IVABRADINE HYDROCHLORIDEDR. KEYUR S. PATEL 225

27-Nov-18 172250824001 Dhruv Nikita Mahendrakumar MRW304P 24 225 MPPharmaceutical Quality



SIMULTANEOUS ESTIMATION OF BENIDIPINE

HYDROCHLORIDE, TELMISARTAN AND CHLORTHALIDONE IN

TABLET

DR. DEEPA R. PATEL 225

27-Nov-18 172250824002 HIRAPARA FENIBEN JAYANTILAL MRW304P 24 225 MPPharmaceutical Quality



VALIDATION OF AMOXYCILLIN AND CLAVULANIC ACID IN

TABLET

Dr. SAMIR C. PATEL 225

27-Nov-18 172250824003 JAIN JUHI ANILKUMAR MRW304P 24 225 MPPharmaceutical Quality


STABILITY INDICATING CHROMATOGRAPHIC METHOD

DEVELOPMENT AND VALIDATION OF BENIDIPINE

HYDROCHLORIDE AND CHLORTHALIDONE IN TABLET


27-Nov-18 172250824004 KACHCHHI RIDDHI RAMESHBHAI MRW304P 24 225 MPPharmaceutical Quality



DEVELOPMENT AND VALIDATION OF SERTACONAZOLE

NITRATE AND ZINC PYRITHIONE IN SHAMPOO


27-Nov-18 172250824005 PANCHAL HINABEN HASUBHAI MRW304P 24 225 MPPharmaceutical Quality



SIMULTANEOUS ESTIMATION OF TRIHEXYPHENIDYL,

THIORIDAZINE AND TRIFLUOPERAZINE IN COMBINED DOSAGE

FORM


27-Nov-18 172250824006 PATEL LAVINA GHANSHYAMBHAI MRW304P 24 225 MPPharmaceutical Quality



DEVELOPMENT AND VALIDATION OF FLUCONAZOLE AND

BECLOMETHASONE DIPROPIONATE IN OINTMENT


27-Nov-18 172250824007 PATEL PINKI RANCHHODBHAI MRW304P 24 225 MPPharmaceutical Quality



DEVELOPMENT AND VALIDATION OF ENROFLOXACIN AND

BROMHEXINE IN COMBINED DOSAGE FORM


27-Nov-18 172250824008 SK MOTIUR RAHAMAN MRW304P 24 225 MPPharmaceutical Quality



DEVELOPMENT AND VALIDATION OF BETAHISTINE AND

DOMPERIDONE IN COMBINED DOSAGE FORM

Dr. SAMIR C. PATEL 225

27-Nov-18 172250824009 VYAS RAMA SHIVKUMAR MRW304P 24 225 MPPharmaceutical Quality



VALIDATION OF SERTACONAZOLE NITRATE AND

BECLOMETHASONE DIPROPIONATE IN COMBINED DOSAGE

FORM


27-Nov-18 172280824002 DHAWAL KOTHARI MRW304P 24 228 MPPharmaceutical Quality

AssuranceOTHER (KINDLY SPECIFY)


ESTIMATION OF LORCASERIN HYDROCHLORIDE.DR. ANURADHA GAJJAR 228

27-Nov-18 172280824003 HAPPY PARIN PATEL MRW304P 24 228 MPPharmaceutical Quality



CHROMATOGRAPHIC METHOD FOR ESTIMATION OF

ALFUZOSIN HYDROCHLORIDE AND SOLIFENACIN SUCCINATE

IN THEIR COMBINED DOSAGE FORM

DR. SINDHU EZHAVA 228

27-Nov-18 172280824006 Shah Jaldhi Hemantbhai MRW304P 24 228 MPPharmaceutical Quality



METHOD FOR ESTIMATION OF DAPAGLIFLOZIN AND ITS

APPLICATION TO STUDY DEGRADATION KINETICS


27-Nov-18 172280824007 SHAH PRIYAL KALPESHKUMAR MRW304P 24 228 MPPharmaceutical Quality


STABILITY INDICATING CHROMATOGRAPHIC METHOD FOR

EFONIDIPINE HYDROCHLORIDE ETHANOLATEDR. ANURADHA GAJJAR 228

27-Nov-18 172420824001 BAGHEL LAXMI SHIVNARAYANSINGH MRW304P 24 242 MPPharmaceutical Quality


DOCUMENTATION IN QUALITY MANAGEMENT SYSTEM (QMS)

AND DATA INTEGRITY IN PHARMACEUTICAL INDUSTRYMS. JIGNA T. PATEL 242

27-Nov-18 172420824003 MANGROLIYA RUCHITA HIMMATBHAI MRW304P 24 242 MPPharmaceutical Quality

AssurancePROCESS VALIDATION

PROSPECTIVE PROCESS VALIDATION OF ANTIINFLAMMATORY

(CORTICOSTEROID) INJECTION SUSPENSION USP 40 MG/MLDR. ANKIT B. CHAUDHARY 242

27-Nov-18 172420824004 PATEL MINALBEN VINODBHAI MRW304P 24 242 MPPharmaceutical Quality


A COMPREHENSIVE AND COMPARATIVE STUDY ON

REGULATIONS OF MEDICAL COUNTERMEASURES IN USA,

EUROPE AND INDIA

DR. ANKIT B. CHAUDHARY 242

27-Nov-18 172450820001 Chaudhary Jigneshkumar Ishwarbhai MRW304P 20 245 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND OPTIMIZATION OF ORODISPERSIBLE

TABLET OF A SELECTIVE APLPHA ADRENERGIC BLOCKING

AGENT AS NEFTOPIDIL

DR. H.D.KAREN 245

27-Nov-18 172450820002 Vaghela Harshkumar Chamanlal MRW304P 20 245 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

PREPARATION AND EVALUATION OF SUSTAINED RELEASE

TABLET OF NIFEDIPINEDR. P. H. PRAJAPATI 245

27-Nov-18 172450824001 PATEL RITUBEN JASHVANTBHAI MRW304P 24 245 MPPharmaceutical Quality


STABILITY STUDY OF SULTAMICILLIN AND ITS TABLET

FORMULATION UNDER ACCELERATED AND STRESS

CONDITION

DR. J. B. DAVE 245

27-Nov-18 172470820001 AGRAWAL HIMANSHU GOPALBHAI MRW304P 20 247 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


PHYSICOCHEMICAL CHARACTERISATION AND IN VITRO

DISSOLUTION ENHANCEMENT OF AGOMELATION USING

SOLID DISPERSION METHOD

MR. VIJAY K. PATEL 247

27-Nov-18 172470820002 GAJERA KAUSHIKBHAI GHANSHYAMBHAI MRW304P 20 247 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF ORODISPERSIBLE

TABLETS OF PALIPERIDONEMR. ANIL G. RAVAL 247

27-Nov-18 172470820003 JOSHI ARJUN LALITBHAI MRW304P 20 247 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF SUBLINGUAL FILMS OF

APIXABANDR. YOGESH K. PATEL 247

27-Nov-18 172470820004 KANANI MANISH BIPINBHAI MRW304P 20 247 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF GASTRORETENTIVE

FLOATING IN-SITU GEL OF ROSIGLITAZONE MALEATEDR. YOGESH K. PATEL 247

27-Nov-18 172470820005 KANCHAN MANDAL M. MRW304P 20 247 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION AND EVALUATION OF BUCCAL TABLETS OF

ACEBUTOLOLDR. DHARA B. PATEL 247

27-Nov-18 172470820007 MEHTA HIR RAJIV KUMAR MRW304P 20 247 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU


GASTRORETENTIVE FLOATING FILMS OF LAFUTIDINEMR. VIJAY K. PATEL 247

27-Nov-18 172470820009 PANDIT VIPULKUMAR DINESHKUMAR MRW304P 20 247 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION AND EVALUATION OF BUCCAL FILMS OF

SAXAGLIPTINMR. VIJAY K. PATEL 247

27-Nov-18 172470820011 PRAJAPATI KAJALBEN ARVINDBHAI MRW304P 20 247 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUTION OF ORALLY DISINTEGRATING

TABLETS OF MIRABEGRONDR. DHARA B. PATEL 247

27-Nov-18 172470820012 SHAH AKASHKUMAR NARESHKUMAR MRW304P 20 247 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF COLON TARGETED

ENTERIC COATED PELLETS OF BUMEDIZONE CALCIUMMR. ANIL G. RAVAL 247

27-Nov-18 172470820013 SHARMA SUNNY SURESHBHAI MRW304P 20 247 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF CONTROLLED RELEASE

OSMOTIC TABLET OF CARVEDILOLMR. ANIL G. RAVAL 247

27-Nov-18 172470820014 TAPNIYA NILESHKUMAR NATHABHAI MRW304P 20 247 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF FLOATING TABLETS OF

FEBUXOSTATDR. YOGESH K. PATEL 247

27-Nov-18 172470824001 ANSARI AFSHANNIKHAT AQEELAHMED MRW304P 24 247 MPPharmaceutical Quality



RP-HPLC METHOD FOR ESTIMATION OF SERTACONAZOLE

NITRATE AND BECLOMETHASONE DIPROPIONATE IN CREAM

MS. ANKITA S. PATEL 247

27-Nov-18 172470824002 DHARU NEETUKUMARI RAJESHBHAI MRW304P 24 247 MPPharmaceutical Quality




NADIFLOXACIN AND CLOBETASOL PROPIONATE IN CREAM

MS. KUNJAL L. VEGAD 247

27-Nov-18 172470824003 HARDIK KIRTIKUMAR BHAVSAR MRW304P 24 247 MPPharmaceutical Quality



ASSAY METHOD FOR ESTIMATION OF TAMSULOSIN

HYDROCHLORIDE AND TOLTERODINE TARTRATE IN CAPSULE

DR. VINAY C. DARJI 247

27-Nov-18 172470824004 MEGHA JINAL MUKESHBHAI MRW304P 24 247 MPPharmaceutical Quality



STABILITY INDICATING RP-HPLC METHOD FOR ESTIMATION OF

BENIDIPINE HCL, TELMISARTAN AND CHLORTHALIDONE IN

TABLET

DR. EKTA D. PATEL 247

27-Nov-18 172470824006 PATEL DHARABEN BHARATKUMAR MRW304P 24 247 MPPharmaceutical Quality




PARACETAMOL AND ZALTOPROFEN IN TABLET

MR. KAUSHIK R. PATEL 247

27-Nov-18 172470824007 PATEL POOJABEN AJAYBHAI MRW304P 24 247 MPPharmaceutical Quality




BRINZOLAMIDE AND BRIMONIDINE TARTRATE IN

OPHTHALMIC SUSPENSION

DR. VINAY C. DARJI 247

27-Nov-18 172470824008 PATEL RINKAL MUKESHBHAI MRW304P 24 247 MPPharmaceutical Quality




OXYCODONE HCL AND NALTREXONE HCL IN CAPSULE

MR. KAUSHIK R. PATEL 247

27-Nov-18 172470824009 PATEL SEEMA NITINBHAI MRW304P 24 247 MPPharmaceutical Quality




AMLODIPINE BESYLATE AND CELECOXIB IN SYNTHETIC

MIXTURE

MS. BHUMI R. PATEL 247

27-Nov-18 172470824010 PATEL UPASANA KANTILAL MRW304P 24 247 MPPharmaceutical Quality




MEROPENEM AND VABORBACTAM IN SYNTHETIC MIXTURE

MR. JAYMIN G. PATEL 247

27-Nov-18 172470824011 PATIL POOJA SATISHBHAI MRW304P 24 247 MPPharmaceutical Quality



RP-HPLC METHOD FOR ESTIMATION OF MICONAZOLE

NITRATE AND HYDROCORTISONE IN CREAM


27-Nov-18 172470824012 Rathod Jinal Harshadkumar MRW304P 24 247 MPPharmaceutical Quality




CLOTRIMAZOLE, CLINDAMYCIN PHOSPHATE AND TINIDAZOLE

CAPSULE


27-Nov-18 172470824013 Salunkhe Suchitra Sunil MRW304P 24 247 MPPharmaceutical Quality


PROCESS VALIDATION OF RIFAMPICIN AND ISONIAZID FILM

COATED TABLETSMR.JAYMIN G. PATEL 247

27-Nov-18 172470824014 VAGH VIRAL VITTHALBHAI MRW304P 24 247 MPPharmaceutical Quality


PROCESS OPTIMIZATION AND PROCESS VALIDATION OF

MYOINOSITOL AND D-CHIRO INOSITOL FILM COATED TABLET MS. BHUMI R. PATEL 247

27-Nov-18 172470824015 VYAS KAJAL SHAILESHKUMAR MRW304P 24 247 MPPharmaceutical Quality




FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE IN

INHALATION POWDER

MS. ANKITA S. PATEL 247

27-Nov-18 172520820001 BULA SANA MOHAMMADHUSAIN MRW304P 20 252 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DEVELOPMENT AND CHARACTERIZATION OF FLOATING-

MUCOADHESIVE TABLET CONTAINING QUETIAPINE

FUMARATE

DR ALPESH D PATEL 252

27-Nov-18 172520820002 Joshi Kishankumar Devendrabhai MRW304P 20 252 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


DESIGN AND DEVELOPMENT OF ORALLY DISINTEGRATING

TABLETS OF DESLORATADINESANJAYKUMAR S PATEL 252

27-Nov-18 172520824001 BHAVSAR DHRUV KAUSHIKBHAI MRW304P 24 252 MPPharmaceutical Quality


METHOD DEVELOPMENT AND VALIDATION OF MESALAZINE

IN HUMAN PLASMA BY LC-MS/MS.DR AMITKUMAR K JOSHI 252

27-Nov-18 172600824005 PATEL AISHWARYA JITENDRA MRW304P 24 260 MPPharmaceutical Quality

AssuranceDISSOLUTION STUDIES

DEVELOPMENT AND VALIDATION OF DISSOLUTION TEST

METHOD FOR FLUNARIZINE, DOMPERIDONE AND

PARACETAMOL IN PHARMACEUTICAL DOSAGE FORM


27-Nov-18 172600824007 THAKKER KRINA SURESHKUMAR MRW304P 24 260 MPPharmaceutical Quality


PROCESS VALIDATION OF OPTIMIZED FORMULATION OF

VENLAFAXINE HYDROCHLORIDE 37.5 MG TABLET DOSAGE

FORM


27-Nov-18 172780820001 DALBANJAN NIKITA SURESHBHAI MRW304P 20 278 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST



TABLETS OF TELMISARTAN SODIUMDR. VIKRAM PANDYA 278

27-Nov-18 172780820003 PANDIT MRUGESH SURESHBHAI MRW304P 20 278 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF FAST DISSOLVING FILMS

OF LINAGLIPTINDR. VIKRAM PANDYA 278

27-Nov-18 172780820005 SOLANKI ARTI NARENDRASINH MRW304P 20 278 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION DEVELOPMENT AND EVALUATION OF BUCCAL

TABLETS OF ZOLPIDEM TARTRATEDR. KINJAL SOLANKI 278

27-Nov-18 172780824001 JANI KRUPA ASHWINKUMAR MRW304P 24 278 MPPharmaceutical Quality


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS

FOR THE SIMULTANEOUS ESTIMATION OF AMBROXOL HCL

AND GUAIFENESIN IN COMBINED PHARMACEUTICAL DOSAGE

FORM

DR RAJESH K PATEL 278

27-Nov-18 172780824002 JANI PRIYAL ASITBHAI MRW304P 24 278 MPPharmaceutical Quality


EQUIPMENT QUALIFICATION OF ELECTRONIC CHECKWEIGHER

IPC 600DR RAJESH K PATEL 278

27-Nov-18 172780824003 KHATRI HEMAXI DEVENDRAKUMAR MRW304P 24 278 MPPharmaceutical Quality


ANNUAL PRODUCT QUALITY REVIEW (APQR) OF LOSARTAN

TABLETS 100 MGDR VIKRAM PANDYA 278

27-Nov-18 172780824004 PATEL HARSHITKUMAR PANKAJBHAI MRW304P 24 278 MPPharmaceutical Quality



FOR THE SIMULTANEOUS ESTIMATION OF FLUCONAZOLE AND

BECLOMETHAZONE DIPROPIONATE IN COMBINED



27-Nov-18 172780824005 PATEL HINAL BALDEVBHAI MRW304P 24 278 MPPharmaceutical Quality



FOR THE SIMULTANEOUS ESTIMATION OF

DEXCHLOPHENERAMINE MELEATE AND BETAMETHASONE IN

COMBINED PHARMACEUTICAL DOSAGE FORM

DR MITALI SHRIMANKER 278

27-Nov-18 172780824006 PUJARA DISHA KIRITKUMAR MRW304P 24 278 MPPharmaceutical Quality



FOR THE SIMULTANEOUS ESTIMATION OF AMBROXOL HCL

AND GUAIFENESIN IN HUMAN PLASMA BY USING LC-MS/MS

DR KINJAL SOLANKI 278

27-Nov-18 172780824007 SHAH SANKET NITINKUMAR MRW304P 24 278 MPPharmaceutical Quality



FOR THE SIMULTANEOUS ESTIMATION OF TICLOPIDINE AND

ASPIRIN IN COMBINED PHARMACEUTICAL DOSAGE FORM


27-Nov-18 172780824008 THAKKAR BHOOMIBEN HASMUKHBHAI MRW304P 24 278 MPPharmaceutical Quality


BIO ANALYTICAL METHOD DEVELOPMENT AND VALIDATION

FOR THE SIMULTANEOUS ESTIMATION OF SOFOSBUVIR AND

LEDIPASVIR IN HUMAN PLASMA BY LC-ESI-MS/MS


27-Nov-18 172860824005 Pandya Shivangi Krupeshchandra MRW304P 24 286 MPPharmaceutical Quality



FOR DETERMINATION OF DILTIAZEM MELATE AND ENALAPRIL

MELATE FROM ITS PHARMACEUTICAL FORMULATION.

DR. PINAK R. PATEL 286

27-Nov-18 172860824010 SHARMA MEENA RAMJILAL MRW304P 24 286 MPPharmaceutical Quality



FOR DETERMINATION OF AMLODIPINE BESYLATE AND

CELECOXIB FROM ITS PHARMACEUTICAL FORMULATION.


27-Nov-18 172860824011 Shukla Rashmi Rammilan MRW304P 24 286 MPPharmaceutical Quality



FOR DETERMINATION OF RIVAROXABAN AND ASPIRIN FROM

SYNTHETIC MIXTURE.


27-Nov-18 172860824012 Sirsiker bhumi prashantbhai MRW304P 24 286 MPPharmaceutical Quality



FOR DETERMINATION OF TOBRAMYCIN AND

FLUOROMETHOLONE ACETATE FROM OPTHALMIC

FORMULATION


27-Nov-18 172860824013 Vasani Priyanka sureshbhai MRW304P 24 286 MPPharmaceutical Quality



FOR DETERMINATION OF PAMBROM AND DICLOFENAC

SODIUM FROM SYNTHETIC MIXTURE.


27-Nov-18 172570824002 Chandrakant Jaiswal MRW304P 24 257 MPPharmaceutical Quality

Assurancestability studies

DEVELOPMENT OF INSTRUMENTAL METHOD FOR THE

DETERMINATION OF BACLOFEN IN PRESENCE OF ITS

DEGRADATION PRODUCTS

Dr. Harsha Umesh Patel 257

28-Nov-18 172020820001 PATEL VISHAKHAKUMARI MAHESHKUMAR MRW304P 20 202 MP PharmaceuticsNANO SUSPENSION/EMULSION,

SEDDS, LIPID BASED DDS

SOLID SELF NANOEMULSIFYING DRUG DELIVERY SYSTEM: A

NOVEL APPROACH FOR THE ORAL ADMINISTRATION OF

POORLY WATER SOLUBLE DRUG

DR. AJAY SOLANKI 202

28-Nov-18 172020820002 Vashi Janu Alkeshkumar MRW304P 20 202 MP Pharmaceutics MULTIPARTICULATE

FORMULATION AND OPTIMIZATION OF ILEO-COLONIC

TARGETED MUCOADHESIVE MICROSPHERES FOR TREATMENT

OF ULCERATIVE COLITIS

DR. SAIKAT PANDE 202

28-Nov-18 172020824001 PATEL TWINCYBEN KIRITBHAI MRW304P 24 202 MPPharmaceutical Quality



HPTLC METHOD FOR PERAMPANEL IN IT’S TABLET DOSAGE

FORM

DR. RAJENDRA MEHTA 202

28-Nov-18 172020824002 THESIYA KRISHNABEN BHARATKUMAR MRW304P 24 202 MPPharmaceutical Quality


DEVELOPMENT & VALIDATION OF STABILITY INDICATING RP-

HPLC METHOD FOR RIOCIGUAT IN TABLET DOSAGE FORM

DR.(MRS) ANANDKUMARI D

CAPTAIN202

28-Nov-18 172050820001 Joshi Deepika Manohar MRW304P 20 205 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FABRICATION AND IN VITRO EVALUATION OF FEBUXOSTAT

TABLET FOR OBTAINING BIPHASIC DRUG RELEASE PROFILEDR. MUKESH GOHEL 205

28-Nov-18 172050820002 MALAV RUPESH MANIAR MRW304P 20 205 MP Pharmaceutics

CO PROCESSED, DC,

TABLET/CAPSULE EXCIPIENTS

AND AT

DEVELOPMENT, CHARACTERIZATION AND EVALUATION OF

DIBASIC CALCIUM PHOSPHATE DIHYDRATE FOR THE

FORMULATION OF SOLID ORAL DOSAGE FORM

DR. MUKESH GOHEL 205

28-Nov-18 172050820003 Panchal Punam Ketankumar MRW304P 20 205 MP Pharmaceutics MISCELANEOUSDEVELOPMENT AND EVALUATION OF MODIFIED RELEASE

PASTILLES BY EMPLOYING QUALITY BY DESIGN APPROACHMR. HARDIK RANA 205

28-Nov-18 172050820004 Patel Ashviniben Dilipbhai MRW304P 20 205 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


DEVELOPMENT AND OPTIMIZATION OF ORAL FORMULATION

OF TADALAFIL BY EMPLOYING QBD APPROACHMR. HARDIK RANA 205

28-Nov-18 172050820005 PATEL KAJOLBEN ARUNKUMAR MRW304P 20 205 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


PREPARATION AND CHARACTERIZATION OF TOPICAL

FORMULATION CONTAINING QUERCETIN AS WOUND

HEALING PHYTOPHARMACEUTICAL

DR. VAISHALI THAKKAR 205

28-Nov-18 172050820006 Raut Jignasaben Devrambhai MRW304P 20 205 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


DISSOLUTION ENHANCEMENT OF A HERBAL DRUG BY

ADOPTING LIQISOLID APPROACH MS. DIPIKA CHAVADA 205

28-Nov-18 172050820007 Tadvi Arunaben Kanchanbhai MRW304P 20 205 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


DISSOLUTION ENHANCEMENT OF BICALUTAMIDE BY

DEVELOPING SOLID DISPERSION EMPLOYING MICROWAVE

OVEN

DR. VAISHALI T. THAKKAR 205

28-Nov-18 172050820008 Tadvi Gaureeben Rajeshbhai MRW304P 20 205 MP Pharmaceutics OTHER (KINDLY SPECIFY)DEVELOPMENT OF DISINTEGRATION CONTROLLED MATRIX

TABLET OF GLIBENCLAMIDEMS. DIPIKA CHAVDA 205

28-Nov-18 172050820009 Udhwani Nikita Haresh MRW304P 20 205 MP Pharmaceutics MULTIPARTICULATE

EXPLORATION OF RESEARCH OPPORTUNITIES IN THE

DEVELOPMENT OF IMMEDIATE RELEASE MINI-TABLETS OF

CILOSTAZOL

DR. MUKESH C. GOHEL 205

28-Nov-18 172050820010 Vyas Shubham Sanjaykumar MRW304P 20 205 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


DEVELOPMENT AND CHARACTERIZATION OF

ROXITHROMYCIN TOPICAL GELDR. VAISHLAI THAKKAR 205

28-Nov-18 172050820011 MS. PAROMITA SAHA MRW304P 20 205 MP Pharmaceutics

CO PROCESSED, DC,


AND AT

MINIMIZATION OF RETARDATION OF DRUG RELEASE FROM

HARD GELATIN CAPSULE DR. MUKESH C. GOHEL 205

28-Nov-18 172050824002 Chunara Kiranben Rameshchandra MRW304P 24 205 MPPharmaceutical Quality



FOR SIMULTANEOUS ESTIMATION OF EMPAGLIFLOZIN AND

METFORMIN HYDROCHLORIDE IN NEWER PHARMACEUTICAL

FORMULATION

DR. PURVI A. SHAH 205

28-Nov-18 172050824003 DESAI JINAL HEMANTKUMAR MRW304P 24 205 MPPharmaceutical Quality

AssuranceHERBAL


FOR ESTIMATION OF BERBERINE AND RETINOIC ACID IN

NOVEL HERBAL FORMULATION USING EXPERIMENTAL DESIGN

DR.KALPANA G. PATEL 205

28-Nov-18 172050824004 PATEL KRISHNA SURESHBHAI MRW304P 24 205 MPPharmaceutical Quality


FORMULATION DEVELOPMENT AND SIMULTANEOUS

ESTIMATION OF TADALAFIL AND DAPOXETINE

HYDROCHLORIDE IN NEWER COMBINED DOSAGE FORM

USING QBD APPROACH

DR. PURVI A. SHAH 205

28-Nov-18 172050824006 Shah Nejal Nitinkumar MRW304P 24 205 MPPharmaceutical Quality



FOR QUANTIFICATION OF NEPAFENAC IN NEWER OPTIMIZED

OPHTHALMIC FORMULATION

DR. KALPANA G. PATEL 205

28-Nov-18 172050824007 Shah Nischay Sunil MRW304P 24 205 MPPharmaceutical Quality


FORMULATION DEVELOPMENT AND ANALYTICAL METHOD

DEVELOPMENT FOR FLUCONAZOLE AND QUERCETIN IN

NOVEL TOPICAL GEL FORMULATION

MR. HITESH G. RAVAL 205

28-Nov-18 172130820001 KM SHALINI SHARMA MRW304P 20 213 MP Pharmaceutics OTHER (KINDLY SPECIFY)

CYCLODEXTRIN BASED NANOSPONGES: AN EFFECTIVE

METHOD FOR DISSOLUTION ENHANCEMENT OF LOW

SOLUBILITY NUTRACEUTICAL

DR ASHOK MAHAJAN 213

28-Nov-18 172130820002 MISTRY JHEEL RAJUBHAI MRW304P 20 213 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF NANOEMULSION BASED

IN-SITU GEL FOR OCULAR DRUG DELIVERY OF ACECLOFENACDR.PRIYAL PATEL 213

28-Nov-18 172130820003 NAZIYA ILYAS GHEEWALA MRW304P 20 213 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


SPRAY DRIED SOLID DISPERSION : AN EFFICIENT METHOD FOR

DISSOLUTION ENHANCEMENT OF ANTI-HIV DRUGDR ASHOK MAHAJAN 213

28-Nov-18 172130820004 PATEL DHRUVI KAMLESHBHAI MRW304P 20 213 MP Pharmaceutics

CO PROCESSED, DC,


AND AT

PREPARATION AND CHARACTERIZATION OF SPRAY DRIED

SOLID DISPERSION OF AN ANTI-DIABETIC DRUG FOR

DISSOLUTION ENHANCEMENT

DR. NAAZNEEN SURTI 213

28-Nov-18 172130820005 PATEL VAISHNAVIBEN PRAVINBHAI MRW304P 20 213 MP Pharmaceutics OTHER (KINDLY SPECIFY)VAGINAL DRUG DELIVERY SYSTEM OF METHOTREXATE FOR

TREATMENT OF RHEUMATOID ARTHRITISDR. NAAZNEEN SURTI 213

28-Nov-18 172130820006 PATEL VRUNDA SANJAYKUMAR MRW304P 20 213 MP Pharmaceutics MISCELANEOUSPREPARATION AND EVALUATION OF DRY POWDER INHALER

FORMULATION FOR PULMONARY DELIVERY OF CEFTAZIDIME.DR.PRIYAL PATEL 213

28-Nov-18 172130820007 SHAH HARDIK SANJAYKUMAR MRW304P 20 213 MP PharmaceuticsVESICULAR DRUG DELIVERY

SYSTEM

DEPOFOAM TECHNOLOGY BASED INTRAMUSCULAR DRUG

DELIVERY OF PREDNISOLONE ACETATE FOR TREATMENT OF

RHEUMATOID ARTHRITIS

DR.PRACHI PANDEY 213

28-Nov-18 172130820008 TELI ANJALIBEN KUSHALCHANDRA MRW304P 20 213 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DEVELOPMENT OF TARGETED FORMULATION OF

BUDESONIDE FOR INFLAMMATORY BOWEL DISEASE

MANAGEMENT

DR. MANISHA S. LALAN 213

28-Nov-18 172130820009 TRIVEDI RUSHI JAWAHARLAL MRW304P 20 213 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF INTRANASAL IN-SITU

GEL OF PRAMIPEXOLE DIHYDROCHLORIDEDR.MEENAKSHI PATEL 213

28-Nov-18 172130824001 JOSHI KRUPABEN PRAVINBHAI MRW304P 24 213 MPPharmaceutical Quality



FOR THE ESTIMATION OF FLIBANSERIN IN THE PRESENCE OF

ITS RELATED SUBSTANCE

DR. FALGUN A. MEHTA 213

28-Nov-18 172130824002 MIRZA NILAMFATEMA MOHAMMADASKARI MRW304P 24 213 MPPharmaceutical Quality



FOR SIMULTANEOUS ESTIMATION OF PITAVASTATIN

CALCIUM AND EZETIMIBE FROM ITS COMBINED TABLET

DOSAGE FORM

DR. VANDANA B. PATEL 213

28-Nov-18 172130824003 NAIR SHREYA RADHAKRISHNAN MRW304P 24 213 MPPharmaceutical Quality


DEVELEOPMENT AND VALIDATION OF ANALYTICAL METHOD

FOR THE ESTIMATION OF POLMACOXIB IN PRESENCE OF ITS

RELATED SUBSTANCES.

DR. FALGUN A. MEHTA 213

28-Nov-18 172130824004 PANCHAL PRACHI VISHNUKUMAR MRW304P 24 213 MPPharmaceutical Quality



FOR THE ESTIMATION OF NETUPITANT IN THE PRESENCE OF

ITS RELATED SUBSTANCE

DR. FARHATJAHAN SHAIKH 213

28-Nov-18 172130824005 PARMAR PAYAL MAHESHBHAI MRW304P 24 213 MPPharmaceutical Quality



FOR ESTIMATION OF VALBENAZINE TOSYLATE IN BULKDR. VANDANA B. PATEL 213

28-Nov-18 172130824006 PRAJAPATI DHRUVI ANILKUMAR MRW304P 24 213 MPPharmaceutical Quality


DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR

ANALYSIS OF ALOGLIPTIN BENZOATE IN THE PRESENCE OF ITS

RELATED SUBSTANCES

DR. SHAILESH KORADIA 213

28-Nov-18 172130824007 TAHILRAMANI POOJA JAGDISH MRW304P 24 213 MPPharmaceutical Quality


DEVELOPMENT AND VALIDATION OF UV AND

CHROMATOGRAPHIC METHODS FOR ESTIMATION OF

MIRABEGRON AND SOLIFENACIN SUCCINATE IN

COMBINATION

DR. DIMAL SHAH 213

28-Nov-18 172130824008 UPADHYAY KHYATIBEN VIJAYKUMAR MRW304P 24 213 MPPharmaceutical Quality


DEVELOPMENT AND VALIDATION OF LIQUID

CHROMATOGRAPHIC METHOD FOR ESTIMATION OF

FIMASARTAN POTASSIUM TRIHYDRATE IN PRESENCE OF ITS

RELATED SUBSTANCES

DR. DIMAL SHAH 213

28-Nov-18 172150827001 BHANDARI KRISHNA KAUSHIKKUMAR MRW304P 27 215 MPPharmaceutical Regulatory

AffairsREGULATORY AFFAIRS

CURRENT REGULATORY REQUIREMENT FOR EXPORT OF SOLID

ORAL DOSAGE FORM IN BRAZIL AND MEXICODR .VINEET JAIN 215

28-Nov-18 172150827002 Chaudhary Reena Bhagawanswaroop MRW304P 27 215 MPPharmaceutical Regulatory


GUIDELINES AND REGULATORY REQUIREMENTS FOR

LABELLING AND PACKAGING OF INJECTIONS IN USA, EUROPE,

INDIA AND CANADA.

DR. RONAK DEDANIA 215

28-Nov-18 172150827003 Dobariya Janki Rasikkumar MRW304P 27 215 MPPharmaceutical Regulatory

AffairsSIMULTENEOUS ESTIMATION

A COMPREHENSIVE STUDY ON REGULATORY REQUIREMENTS

FOR VACCINES IN USA, EUROPE AND CANADA. DR. RONAK DEDANIA 215

28-Nov-18 172150827004 Juneja Parul jitender MRW304P 27 215 MPPharmaceutical Regulatory


REGULATORY GUIDELINES OF HAZARD ANALYSIS CRITICAL

CONTROL POINT (HACCP) WITH COMPREHENSIVE STUDY ON

STANDARDS AND CERTIFICATION PROCEDURES IN USA,

AUSTRALIA AND INDIA.


28-Nov-18 172150827005 MAHLA SWETA MAVJIBHAI MRW304P 27 215 MPPharmaceutical Regulatory


A COMPARATIVE STUDY OF REGULATORY REQUIREMENTS

AND GUIDELINES FOR MEDICAL DEVICES IN USA,JAPAN AND

CANADA


28-Nov-18 172150827006 PANCHOLI HARSH JAYKUMAR MRW304P 27 215 MPPharmaceutical Regulatory

AffairsOTHER (KINDLY SPECIFY)

TO STUDY THE REGULATORY REQUIREMENT FOR NEW DRUG

APPLICATION IN US, EUROPE, JAPANDR. RONAK DEDANIA 215

28-Nov-18 172150827008 TAILOR BRINDA ASHISHKUMAR MRW304P 27 215 MPPharmaceutical Regulatory


CURRENT STATUS OF GENERIC DRUG APPROVAL PROCESS IN

UNITED STATES OF AMERICA AND EUROPEAN UNIONDR .VINEET JAIN 215

28-Nov-18 172150827009YADAV KUSUM KUMARI SHREE DINESH

KUMARMRW304P 27 215 MP

Pharmaceutical Regulatory


NAVIGATING REGULATORY FRAMEWORK TO DEFEAT ZIKA

VIRUS IN USA AND EUDR .VINEET JAIN 215

28-Nov-18 172230823002 Patel Keshaben Manojbhai MRW304P 23 223 MP Pharmaceutical Analysis OTHER (KINDLY SPECIFY)


FOR THE QUANTIFICATION OF MACITENTAN IN BULK AND


DR. USMANGANI K.

CHHALOTIYA223

28-Nov-18 172230823003 YADAV PREETIBEN NARESHKUMAR MRW304P 23 223 MP Pharmaceutical Analysis OTHER (KINDLY SPECIFY)

DEVELOPMENT AND VALIDATION OF CHROMATOGRAPHIC

AND UV-VISIBLE SPECTROSCOPIC METHODS FOR

QUANTIFICATION OF MIRABEGRON IN BULK AND


DR. USMANGANI K.

CHHALOTIYA223

28-Nov-18 172230828001 DESAI ANJALI DATTATRAY MRW304P 28 223 MP Pharmaceutical Technology OTHER (KINDLY SPECIFY)

DEVELOPMENT AND EVALUATION OF SPRAY DRIED

INHALABLE DRY POWDER OF POSACONAZOLE FOR

PULMONARY ASPERGILLOSIS

DR. ALIASGAR J KUNDAWALA 223

28-Nov-18 172230828002 KAPADIA DHWANI PREYAS MRW304P 28 223 MP Pharmaceutical TechnologyBUCO/MUCOADHESIVE, TDDS,


FORMULATION AND CHARACTERIZATION OF LIPOSOME

BASED INTRA-NASAL DELIVERY OF ARIPIPRAZOLEDR. ALIASGAR J KUNDAWALA 223

28-Nov-18 172350820001 Bariya Hiralbhai Ranchhodbhai MRW304P 20 235 MP Pharmaceutics

CO PROCESSED, DC,


AND AT

FORMULATION DEVELOPMENT AND CHARACTERIZATION OF

DIRECTLY COMPRESSIBLE TABLETS OF NISOLDIPINE LOADED

SPHERICAL CRYSTAL AGGLOMERATES

DR. HITESH JAIN 235

28-Nov-18 172350820002 Dindod Swetalben Babubhai MRW304P 20 235 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


DESIGN AND CHARACTERIZATION OF MICROSPONGE LOADED

CONTROLLED RELEASE TOPICAL GEL OF LULICONAZOLEDR. HITESH JAIN 235

28-Nov-18 172350820003 NEHATE SHWETA BHAGWAN MRW304P 20 235 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION DEVELOPMENT AND OPTIMIZATION OF

MUCOADHESIVE IN SITU NASAL GEL CONTAINING

MONTELUKAST SODIUM

DR. HITESH JAIN 235

28-Nov-18 172440820001 DARJI JIGNESHBHAI MUKESHBHAI MRW304P 20 244 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


DEVELOPMENT AND EVALUATION OF MOUTH DISSOLVING

FILM OF RALOXIFENE HYDROCHLORIDEMR. MEHUL B. VYAS 244

28-Nov-18 172440820003 PATEL RIKIN RAMESH MRW304P 20 244 MP Pharmaceutics OTHER (KINDLY SPECIFY)FORMULATION, DEVELOPMENT AND EVALUATION OF

MEDICATED CHEWING GUM OF AVANAFILM. RAHIL G. BHURA 244

28-Nov-18 172460824001 CHAUDHARI URVASHIBEN ANILKUMAR MRW304P 24 246 MPPharmaceutical Quality


STABILITY INDICATING ANALYTICAL METHOD

DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS

ESTIMATION OF ENROFLOXACIN AND BROMHEXINE HCL IN

BULK AND PHARMACEUTICAL DOSAGE FORM

DR ANKITA BHAVSAR 246

28-Nov-18 172460824002 DESAI PAMIL SHAMJIBHAI MRW304P 24 246 MPPharmaceutical Quality



METHOD FOR ESTIMATION OF RIOCIGUAT IN BULK AND



28-Nov-18 172460824004 PRACHI GUPTA MRW304P 24 246 MPPharmaceutical Quality

AssuranceQUALITY RISK MANAGEMENT

A SYSTEMATIC APPROACH TO NEW PRODUCT

INTRODUCTION WITH EMPHASIS ON THE CONTAINMENT

STRATEGIES AND QUALITY RISK MANAGEMENT


28-Nov-18 172460824005 SONI FALAKKUMAR SUBHASHCHANDRA MRW304P 24 246 MPPharmaceutical Quality


FORMULATION AND ANALYTICAL METHOD DEVELOPMENT

OF IVACAFTOR CONTAINING PHARMACEUTICAL DOSAGE

FORM


28-Nov-18 172820824001 PATEL BIRAJKUMAR VIJAYBHAI MRW304P 24 282 MPPharmaceutical Quality


STABILITY INDICATING CHROMATOGRAPHIC METHOD FOR

DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS

ESTIMATION OF FLUCONAZOLE AND BECLOMETHASONE

DIPROPIONATE IN ITS PHARMACEUTICAL DOSAGE FORM BY

HPLC.

MRS. GEETA V. CHAUDHARI 282

28-Nov-18 172820824002 PATEL SUNNY HEMANTKUMAR MRW304P 24 282 MPPharmaceutical Quality


DEVELOPMENT AND VALIDATION OF LIQUID

CHROMATOGRAPHIC METHOD FOR SIMULTANEOUS

ESTIMATION OF DOXOPHYLLINE AND ACEBROPHYLLINE IN

BULK AND COMBINATION DOSAGE FORM.

DR. M.B.SHANKAR 282

28-Nov-18 172820824004 RATHAVA ATULBHAI JAGDISHBHAI MRW304P 24 282 MPPharmaceutical Quality


DEVELOPMENT AND VALIDATION OF STABILITY

INDICATING RP-HPLC METHOD FOR ESTIMATION OF

ULIPRISTAL ACETATE IN ITS BULK AND FORMULATION.

MRS. GEETA V. CHAUDHARI 282

28-Nov-18 172820824005 SUTHAR ROSHAN JAGADISHBHAI MRW304P 24 282 MPPharmaceutical Quality



RP-HPLC METHOD FOR ESTIMATION OF EFONIDIPINE

HYDROCHLORIDE ETHANOLATE IN TABLET DOSAGE FORM

DR. M.B.SHANKAR 282

28-Nov-18 172880827001 Ansari Daraksha Muhammad MRW304P 27 288 MPPharmaceutical Regulatory


A STUDY ON REGISTRATION PROCESS FOR MOISTURIZING

CREAM AND MOISTURIZING LOTION IN INDIA, USA,

EUROPEAN UNION COUNTRIES, TANZANIA AND ETHIOPIA

MR. FENIL SHAH

28-Nov-18 172880827002 BATADA NORIN BARKATBHAI MRW304P 27 288 MPPharmaceutical Regulatory


COMPARISON OF REGULATORY REQUIREMENTS AS PER

USFDA & EMA FOR IMMEDIATE RELEASE AND EXTENDED

RELEASE ORAL FORMULATIONS AND COMPILATION OF

MODULE 3 AND 5 AS PER EMA

MR. NAGESH NANDA

28-Nov-18 172880827003 DEVADHA MEHULBHAI RAJNIKANT MRW304P 27 288 MPPharmaceutical Regulatory


IMPLICATIONS OF CHANGE IN GUIDANCE FOR EXCIPIENT

CONCENTRATION ON REGISTRATION OF AMLODIPINE TABLET

IN USA & EU COUNTRIES

DR. RAJESH PARIKH 288

28-Nov-18 172880827004 GANDHI HANSAL VIJAY MRW304P 27 288 MPPharmaceutical Regulatory


A STUDY ON REGISTRATION PROCESS OF GENERIC

BUDESONIDE DRY POWDER INHALER AS PER USFDADR. RAJESH PARIKH 288

28-Nov-18 172880827005 GOHEL SAGAR KISHORBHAI MRW304P 27 288 MPPharmaceutical Regulatory


A STUDY ON SUMMARY TECHNICAL DOCUMENTATION (STED)

FOR TRANSCATHETER SEPTAL OCCLUDER AS PER

INTERNATIONAL MEDICAL DEVICE REGULATORS FORUM

(IMDRF)

DR. ANAND SHAH

28-Nov-18 172880827006 JADAV RAHUL KIRITKUMAR MRW304P 27 288 MPPharmaceutical Regulatory


A STUDY ON REGULATORY REQUIREMENTS TO PREVENT

COUNTERFEIT DRUGSMR. NIRAV CHOKSHI

28-Nov-18 172880827007 JAGANI DHARMESHKUMAR UKABHAI MRW304P 27 288 MPPharmaceutical Regulatory


PREPARATION OF DRAFT ABBREVIATED NEW DRUG

APPLICATION (ANDA) FOR OSELTAMIVIR CAPSULE AS PER

USFDA

DR. ANAD SHAH

28-Nov-18 172880827008 PATEL PANKTIBEN KIRTIKUMAR MRW304P 27 288 MPPharmaceutical Regulatory


COMPARISON OF REGULATORY REQUIREMENTS AS PER

USFDA & EMA FOR DELAYED RELEASE AND EXTENDED

RELEASE ORAL FORMULATIONS AND COMPILATION OF

MODULE 3 AND 5 AS PER EMA

MR. KASHYAP THUMMAR 288

28-Nov-18 172880827009 PATEL YAGNESHKUMAR VINODBHAI MRW304P 27 288 MPPharmaceutical Regulatory


A STUDY ON REGISTRATION PROCESS OF BIOSIMILAR

PRODUCT - RITUXIMAB INJECTION - AS PER EMAMR. FENIL SHAH

28-Nov-18 172880827010 Shipra Vijayesh Pandey MRW304P 27 288 MPPharmaceutical Regulatory


NALOXONE HCL NASAL SPRAY : DRAFT DOSSIER PREPARATION

FOR ANDS AS PER HEALTH CANADADR. ANAND SHAH

28-Nov-18 172880827011 THAKKAR RAGHAV ATMARAMBHAI MRW304P 27 288 MPPharmaceutical Regulatory


REGULATORY CONSIDERATION FOR IMPORT & REGISTRATION

OF HEMODIALYSER IN INDIA & EXPORT IN MEMBER

COUNTRIES OF ASEAN

MR. KASHYAP THUMMAR 288

29-Nov-18 172020822001 TARAPRA ANKITABEN MOHANBHAI MRW304P 22 202 MP Pharmaceutical Chemistry OTHER (KINDLY SPECIFY)DESIGN, SYNTHESIS AND ANTI-ALZHEIMER ACTIVITY OF

NOVEL CHROMAN DERIVATIVESDR. VIPUL VAGHELA 202

29-Nov-18 172020826001 PATEL KAJAL DHANJIBHAI MRW304P 26 202 MP Pharmacognosy HERBAL RESEARCHPHARMACOGNOSTICAL, PHYTOCHEMICAL AND

PHARMACOLOGICAL EVALUATION OF RORIPPA INDICADR.(MRS) MONA KUKKAR 202

29-Nov-18 172120820001 Bhanderi Brijesh Ashokbhai MRW304P 20 212 MP PharmaceuticsNANO SUSPENSION/EMULSION,


DESIGN AND OPTIMIZATION OF LUTEIN LOADED SOLID LIPID

NANOPARTICLES FOR OPTHALMIC DELIVERYDR S R SHAH 212

29-Nov-18 172120820002 BHATT UKTI JANAKBHAI MRW304P 20 212 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

STUDIES IN APPLICATION OF HOT MELT EXTRUSION

TECHNIQUE IN DEVELOPMENT OF DELAYED RELEASE

FENOFIBRATE WITH IMPROVED DISSOLUTION.

DR S R SHAH 212

29-Nov-18 172120820003 BHOLA JAYDIPKUMAR HAJABHAI MRW304P 20 212 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


LIQUISOLID TABLET OF EFAVIRENZ FOR IMPROVING

DISSOLUTION CHARACTERISTICS: DESIGN, DEVELOPMENT

AND OPTIMIZATION

DR. M. M. SONIWALA 212

29-Nov-18 172120820004 CHRISTIAN PRAJAL MUKESHBHAI MRW304P 20 212 MP Pharmaceutics MULTIPARTICULATEFORMULATION AND EVALUATION OF LAFUTIDINE LIQUISOLID

PELLETS FOR ENHANCEMENT OF IN-VITRO DISSOLUTION .DR J S PAUN 212

29-Nov-18 172120820005 CHUDASAMA TARUN RAMESHBHAI MRW304P 20 212 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF EXTENDED RELEASE

TABLET OF NIACIN.DR J R CHAVDA 212

29-Nov-18 172120820006 GELHOR HIMANI BABUBHAI MRW304P 20 212 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF SUSTAINED RELEASE

FLOATING TABLET OF CINNARIZINE.DR D R BHIMANI 212

29-Nov-18 172120820007 makvana vaghabhai dulabhai MRW304P 20 212 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


SOLID DISPERSION AS AN APPROACH FOR SOLUBILITY AND

DISSOLUTION ENHANCEMENT OF DARUNAVIR.DR M M SONIWALA 212

29-Nov-18 172120820008 MAVANI CHINTAN PRAVINBHAI MRW304P 20 212 MP Pharmaceutics

CO PROCESSED, DC,


AND AT

DEVELOPMENT AND CHARACTERIZATION OF NOVEL CO-

PROCESSED EXCIPIENT OF TRICALCIUM CITRATE BY SPRAY

DRYING.

DR R D PARMAR 212

29-Nov-18 172120820010 PATEL JETALBEN VASANTBHAI MRW304P 20 212 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


MEDICATED CHOCOLATE CONTAINING CEFIXIME TRIHYDRATE:

A NOVEL SOLID DOSAGE FORM FOR PEDIATRIC PATIENTS.K A PATEL 212

29-Nov-18 172120820011 PRAJAPATI RAVIRAJ RAMESHKUMAR MRW304P 20 212 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


DESIGN AND EVALUATION OF TRANSDERMAL PATCH

CONTAINING ANTIEMETIC DRUGDR. J M PATEL 212

29-Nov-18 172120820012 PRAJAPATI URVASHI RAMESHBHAI MRW304P 20 212 MP Pharmaceutics

CO PROCESSED, DC,


AND AT

PHYSICOCHEMICAL PROPERTY IMPROVEMENT OF

CEFPODOXIME PROXETIL BY CO PROCESSINGDR. JAYANT R. CHAVDA 212

29-Nov-18 172120820013 SAKHIYA DHRUV CHANDRAKANTBHAI MRW304P 20 212 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


PREPARATION AND EVALUTION OF ITRACONAZOLE TOPICAL

NANOGELDR C H BORKHATARIYA 212

29-Nov-18 172120820014 SANGHANI DIVYABEN VINODBHAI MRW304P 20 212 MP Pharmaceutics

CO PROCESSED, DC,


AND AT

AUGMENTATION OF PHYSICOCHEMICAL PROPERTIES OF

CEFUROXIME AXETIL BY SPHERICAL AGGLOMERATION.DR R D PARMAR 212

29-Nov-18 172120824001 Chavda Meghaben MRW304P 24 212 MPPharmaceutical Quality



FOR ESTIMATION OF GENOTOXIC IMPURITIES IN RANOLAZINE

API BY GAS CHROMATOGRAPHY

DR. ASHOK B. PATEL 212

29-Nov-18 172120824002 CHOUDHARY JYOTISHNA BHOOPALSINGH MRW304P 24 212 MPPharmaceutical Quality



THE ESTIMATION OF ARTEMETHER AND LUMEFANTRINE IN

MARKETED FORMULATION BY UPLC


29-Nov-18 172120824003 DHADUK AKTABEN RAMESHBHAI MRW304P 24 212 MPPharmaceutical Quality


QUALITY BY DESIGN APPROACH TO FIND DESIGN SPACE IN

THE DEVELOPMENT OF RP-HPLC METHOD FOR ESTIMATION

OF AMITRIPTYLINE HYDROCHLORIDE BY CENTRAL COMPOSITE

DESIGN (CCD)

MR. AJAY I. PATEL 212

29-Nov-18 172120824005 JANI SHIVANI NILESHKUMAR MRW304P 24 212 MPPharmaceutical Quality


STUDY OF REGULATORY REQUIREMENTS FOR

PHARMACEUTICALS IN NON-EUROPEAN UNION MEMBER

STATES LIKE KOSOVO, UKRAINE AND SERBIA

DR. NILESH K. PATEL 212

29-Nov-18 172120824006 JETHAVA PALAKBEN NANDLALBHAI MRW304P 24 212 MPPharmaceutical Quality


EVALUATION OF INSTABILITY ISSUE IN PAEDIATRIC DRY SYRUP

OF CEPHALOSPORIN ANTIBIOTIC IN COMBINATION WITH

CLAVULANIC ACID

DR. NILESH K. PATEL 212

29-Nov-18 172120824007 KATESHIYA GOVIND AMRUTLAL MRW304P 24 212 MPPharmaceutical Quality



FOR SIMULTANEOUS ESTIMATION OF NAPROXAN AND

DIPHENHYDRAMINE IN K3EDTA HUMAN PLASMA BY USING LC-

ESI-MS/MS


29-Nov-18 172120824008 KHATRI AKSHALIBEN RAMCHANDRA MRW304P 24 212 MPPharmaceutical Quality



FOR ESTIMATION OF DOFETILIDE IN K3EDTA HUMAN PLASMA

BY USING LC-ESI-MS/MS


29-Nov-18 172120824009 KULKARNI POOJA CHANDRAKANT MRW304P 24 212 MPPharmaceutical Quality



FOR ESTIMATION OF DOSULEPIN HYDROCHLORIDE IN K3EDTA

HUMAN PLASMA BY USING LC-ESI-MS/MS

DR.AMITKUMAR J .VYAS 212

29-Nov-18 172120824010 MODH JAIVIK HITESHKUMAR MRW304P 24 212 MPPharmaceutical Quality


DEVELOPMENT AND VALIDATION OF DICLOFENAC

DIETHYLAMINE TOPICAL SOLUTION BY RP-HPLC METHODDR. NILESH K. PATEL 212

29-Nov-18 172120824011 PARMAR ANKUR MOHANBHAI MRW304P 24 212 MPPharmaceutical Quality



FOR ESTIMATION OF VARENICLINE TARTRATE USING K3EDTA

HUMAN PLASMA BY LC-ESI-MS/MS


29-Nov-18 172120824012 PATEL KRUPALIBEN JAGADISHBHAI MRW304P 24 212 MPPharmaceutical Quality


RP-UPLC METHOD DEVELOPMENT AND VALIDATION FOR

SIMULTANEOUS ESTIMATION OF DAPAGLIFLOZIN AND

METFORMIN HYDROCHLORIDE IN BULK AND TABLET DOSAGE

FORM


29-Nov-18 172120824013 PATEL RUPALBEN ASHOKBHAI MRW304P 24 212 MPPharmaceutical Quality



ASSAY METHOD FOR SIMULTANEOUS ESTIMATION OF

AMLODIPINE BESYLATE AND CELECOXIB IN SYNTHETIC

MIXTURE BY RP-HPLC


29-Nov-18 172120824015 SHARMA JIGNASHA KRUSHNAKANT MRW304P 24 212 MPPharmaceutical Quality



OF FLUCYTOSINE IN K3EDTA HUMAN PLASMA BY USING LC-

ESI-MS/MS


29-Nov-18 172280822001 BORANA VIPUL LAXMANBHAI MRW304P 22 228 MP Pharmaceutical ChemistryMEDICINAL CHEMISTRY

(ANTIDIABETICS)

DESIGN, SYNTHESIS AND EVALUATION OF SOME

HETEROCYLCIC COMPOUNDS AS ANTIDIABETIC AGENTSDR. ANURADHA K GAJJAR 228

29-Nov-18 172280822003 Harshita Bodha MRW304P 22 228 MP Pharmaceutical Chemistry MEDICINAL CHEMISTRY

DESIGN, MOLECULAR MODELLING, SYNTHESIS AND ANTI-

INFLAMMATORY ACTIVITY OF SOME SUBSTITUTED 5-

MEMBERED HETEROCYCLES

DR. BEENKUMAR R. PRAJAPATI 228

29-Nov-18 172280822004 JAHA MIRAJ SANJAY MRW304P 22 228 MP Pharmaceutical Chemistry MEDICINAL CHEMISTRYDESIGN AND SYNTHESIS OF SOME NEW BENZOXAZOLE

DERIVATIVES AS ANTI-OBESITY AGENTSDR. DIPEN K. SUREJA 228

01-Dec-18 172280825002 DOBARIYA KOMAL MRW304P 25 228 MP PharmacologyMETABOLIC DISORDER ( PLEASE

SPECIFY DISORDER)

EVALUATE THE THERAPEUTIC POTENTIAL OF CHRYSIN IN TYPE -

2 DIABETES AND ITS COMPLICATIONSDR. ANITA A MEHTA 228

01-Dec-18 172280825003 GORAKHIYA MONIKA SHAILESHBHAI MRW304P 25 228 MP PharmacologyMETABOLIC DISORDER ( PLEASE

SPECIFY DISORDER)

ASSESSMENT OF INSULIN EFFECT IN HYPOTHYROIDISM AND

OBESITY IN RATSDR. MUSTAKIM M. MANSURI 228

29-Nov-18 172310820001 Balas Mayur Vashrambhai MRW304P 20 231 MP PharmaceuticsNANO SUSPENSION/EMULSION,


FORMULATION AND EVALUATION OF NIOSOMAL GEL OF

VORICONAZOLE FOR SEVERE FUNGAL INFECTIONDR. SANDIP PATEL 231

29-Nov-18 172310820002 Garachar Dhaval Ranabhai MRW304P 20 231 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND CHARACTERIZATION OF ACARBOSE

OSMOTIC TABLETMR. SUMIT CHAKRABORTY 231

29-Nov-18 172310820003 KALARIA VISHWA JITENDRABHAI MRW304P 20 231 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DESIGN AND EVALUATION OF INSITU GEL EYE DROPS

CONTAINING NANOPARTICLES OF GEMIFLOXACIN MESYLATEMR. SUMIT CHAKRABORTY 231

29-Nov-18 172310820004 KARELIA KHANJAN JAYSUKH MRW304P 20 231 MP Pharmaceutics

CO PROCESSED, DC,


AND AT

FORMULATION AND EVALUATION OF NAPROXEN SODIUM

TABLETS USING CO-PROCESSED EXCIPIENTSDR. SANDIP PATEL 231

29-Nov-18 172540822001 DHARASANDIYA ARZOO PRABHUDAS MRW304P 22 254 MP Pharmaceutical ChemistryMEDICINAL CHEMISTRY

(ANTICANCER)

SYNTHESIS OF NEW BRIDGEHEAD NITROGEN HETEROCYCLES

AS POTENTIAL ANTICANCER AGENTSDR. M. N. NOOLVI 254

29-Nov-18 172540822002 JOSHI NIDHIBEN BHASKARBHAI MRW304P 22 254 MP Pharmaceutical ChemistryMEDICINAL CHEMISTRY

(ANTICANCER)

SYNTHESIS OF NEW QUINAZOLINE DERIVATIVES AS

ANTICANCER AGENTSMS. MONIKA KAKADIYA 254

29-Nov-18 172540822003 MOGAL AZMIN MAHERVAN MRW304P 22 254 MP Pharmaceutical ChemistryMEDICINAL CHEMISTRY

(ANTICANCER)

SYNTHESIS OF NEW TAMOXIFEN ANALOGUES AS POTENTIAL

ANTICANCER AGENTSDR. M. N. NOOLVI 254

29-Nov-18 172540822004 PATEL SAMEERA SULEMAN MRW304P 22 254 MP Pharmaceutical Chemistry MEDICINAL CHEMISTRYSYNTHESIS AND EVALUATION OF NEW 7-HYDROXY

COUMARIN DERIVATIVES AS ANTI- ALZHEIMER AGENTSDR. MORE UTTAM 254

29-Nov-18 172540822005 PATEL ZOFINA IKBAL MRW304P 22 254 MP Pharmaceutical ChemistryMEDICINAL CHEMISTRY

(ANTICANCER)

SYNTHESIS OF NEW CANTHARIDIN DERIVATIVES AS

POTENTIAL ANTICANCER AGENTSDR. M. N. NOOLVI 254

29-Nov-18 172540822007 Rahevar Vidhikumari Bhupeshkumar MRW304P 22 254 MP Pharmaceutical Chemistry MEDICINAL CHEMISTRYSYNTHESIS AND EVALUATION OF NEW FLAVONOID

DERIVATIVES AS ANTI-ALZHEIMER AGENTSDR. MORE UTTAM 254

29-Nov-18 172540822008 SINGH RAMIYA TILAKDHARI MRW304P 22 254 MP Pharmaceutical Chemistry MEDICINAL CHEMISTRYSYNTHESIS OF NEW QUINOLINE DERIVATIVES AS

ANTITUBERCULAR AGENTSMS. MONIKA KAKADIYA 254

29-Nov-18 172540822009 Zalavadiya Vivek Sureshbhai MRW304P 22 254 MP Pharmaceutical ChemistryMEDICINAL CHEMISTRY

(ANTICANCER)

SYNTHESIS OF NEW CHROMAN-4-ONE DERIVATIVES AS

POTENTIAL ANTICANCER AGENTSDR. M. N. NOOLVI 254

29-Nov-18 172630824001 PATEL SAPANA JOITARAM MRW304P 24 263 MPPharmaceutical Quality


RP-HPLC METHOD FOR DETERMINATION OF ADAPALENE

USING CENTRAL COMPOSITE DESIGN DR. SHITAL FALDU 263

29-Nov-18 172640820002 BHAKHOTRA RUPABEN JADAVBHAI MRW304P 20 264 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST



FILM OF ZOLPIDEM TARTRATEDR RAMESH B. PARMAR 264

29-Nov-18 172640820003 GADHVI SIDDHI SANJAYDAN MRW304P 20 264 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF ORO DISPERSIBLE

TABLETS OF ONDANSETRON HYDROCHLORIDEDR RAMESH B. PARMAR 264

29-Nov-18 172670828001 PATEL BHUMI BHARAT MRW304P 28 267 MP Pharmaceutical TechnologyBUCO/MUCOADHESIVE, TDDS,


FORMULATION AND EVALUATION OF MUCOADHESIVE

MICROEMULSION OF RESVERATROL FOR NOSE TO BRAIN

DELIVERY IN TREATMENT OF ALZHEIMER DISEASE

DR. PRAKASH SUKHRAMANI 267

29-Nov-18 172670828002 PITRODA SHIVANGI HARESHBHAI MRW304P 28 267 MP Pharmaceutical Technology

CO PROCESSED, DC,


AND AT

FORMULATION AND EVALUATION OF IMMEDIATE RELEASE

SOLID ORAL DOSAGE FORM OF ANTI FUNGAL DRUGDR. PRAKASH SUKHRAMANI 267

29-Nov-18 172670828003 SORATHIYA VIPUL VINODBHAI MRW304P 28 267 MP Pharmaceutical Technology MISCELANEOUSDISSOLUTION ENHANCEMENT OF LERCANIDIPINE HCL USING

LIQUID SOLID COMPACT TECHNIQUE

DR. MAHESHKUMAR

SENGHANI267

29-Nov-18 172690820001 Bhuva Mitalben Dineshbhai MRW304P 20 269 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DESIGN, FORMULATION AND EVALUATION OF PRESS COATED

PULSATILE DRUG DELIVERY SYSTEM OF AZILSARTAN

MEDOXOMIL TABLET

FORAM AMRUTIYA 269

29-Nov-18 172690820002 PANKHANIYA HIMANSU PRAVINBHAI MRW304P 20 269 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION, EVALUATION AND OPTIMIZATION OF

SUSTAINED RELEASE DRUG DELIVERY SYSTEM OF CISAPRIDE

TABLET

RAM DARSHIT 269

29-Nov-18 172690820004 Raninga Tushar Kishorbhai MRW304P 20 269 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DESIGN, DEVELOPMENT AND EVALUTION OF BILAYER TABLET

OF PIOGLITAZONE AND PHENFORMIN FOR EXTENDED

RELEASE SYSTEM

SHEETAL BUDDHADEV 269

29-Nov-18 172690824001 Savaliya Umang Yogeshkumar MRW304P 24 269 MPPharmaceutical Quality


DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS

ESTIMATION OF RALTEGRAVIR IN SOLID DOSAGE FORM BY

HPLC

DR SIBAJI SARKAR 269

29-Nov-18 172690824002 SHAH JIMIT BHARATKUMAR MRW304P 24 269 MPPharmaceutical Quality

AssurancePROCESS VALIDATION PROCESS VALIDATION OF ARTEMETHER INJECTION DR SIBAJI SARKAR 269

29-Nov-18 172690820003 PATEL JAYKUMAR KANUBHAI MRW304P 20 269 MP PharmaceuticesDELAYED/EXTENDED

RELEASE,FLOATING, INSITU


FLOATING TABLET OF BISOPROLOL FUMARATE FOR GASTRO

RETENTIVE DRUG DELIVERY

SHEETAL BUDDHADEV 269

30-Nov-18 172150820001 HITESH SANJAY BAKAS MRW304P 20 215 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND DEVELOPMENT OF RAFT FORMING

FLOATING DRUG DELIVERY SYSTEM FOR SUSTAIN DRUG

RELEASE

MR. SENTHIL KUMAR R. 215

30-Nov-18 172150820002 PARMAR HIRENKUMAR NARANBHAI MRW304P 20 215 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

TO STUDY THE EFFECT OF HYDROALCOHOLIC MIDEA ON

DRUG RELEASE BEHAVIOR OF EXTENDED RELEASE TABLET

CONTAINING AN ANTI AGINAL DRUG


30-Nov-18 172150820004 YADAV AJAY CHHOTELAL MRW304P 20 215 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND DEVELOPMENT OF INSITU GEL

CONTAINING ANTIMICROBIAL DRUG LOADED LIPOSOMAL

FOR PERIODONTITIS


30-Nov-18 172150824001 CHISTI ZENAB MOHD MASOOD MRW304P 24 215 MPPharmaceutical Quality


QBD APPROACH FOR DEVELOPMENT AND VALIDATION OF

NAPROXEN AND ESOMEPRAZOLE MAGNESIUM TRIHYDRATE

IN COMBINED DOSAGE FORM BY HPLC

DR. ZARNA DEDANIA 215

30-Nov-18 172150824002 GUPTA VANDANA BARJENDRA MRW304P 24 215 MPPharmaceutical Quality


UV SPECTROSCOPIC AND HPLC METHODS DEVELOPMENT

AND VALIDATION OF FLUPIRTINE MALEATE AND TRAMADOL

HYDROCHLORIDE IN COMBINED PHARMACEUTICAL DOSAGE

FORM.


30-Nov-18 172150824003 KERIWALA TEJAL MANOJKUMAR MRW304P 24 215 MPPharmaceutical Quality


DEVELOPMENT AND VALIDATION OF UV SPECTROSCOPIC AND

HPLC METHODS FOR LULICONAZOLE AND BECLOMETHASONE

DIPROPIONATE IN COMBINED PHARMACEUTICAL DOSAGE

FORM.

DR. GHANSHYAM SHANGHANI 215

30-Nov-18 172150824004 PRAJAPATI RICHA ATULBHAI MRW304P 24 215 MPPharmaceutical Quality


QBD APPROACH TO HPLC METHOD DEVELOPMENT AND

VALIDATION FOR THE ESTIMATION OF FLUOXETINE

HYDROCHLORIDE AND OLANZAPINE IN PHARMACEUTICAL

DOSAGE FORM.


30-Nov-18 172150824005 SHAH ABHISHEKKUMAR BHARATKUMAR MRW304P 24 215 MPPharmaceutical Quality


DEVELOPMENT AND VALIDATION OF UV SPECTROSCOPIC AND

HPLC METHODS FOR ZONISAMIDE AND CILOSTAZOL IN

SYNTHETIC MIXTURE.


30-Nov-18 172390820001 BEHERA SHREEKANT SHIVRAM MRW304P 20 239 MP Pharmaceutics OTHER (KINDLY SPECIFY)FORMULATION AND DEVELOPMENT OF POLYMERIC MICELLE

FOR DISSOLUTION ENHANCEMENT OF EXEMESTANEDR. KOMAL PARMAR 239

30-Nov-18 172390820002 BHANDARI RINAL HASMUKHRAI MRW304P 20 239 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION, EVALUATION AND OPTIMIZATION OF IN-SITU

NASAL GELMR. TULARAM BAROT 239

30-Nov-18 172390820003 CHAUHAN VRUTTIKUMARI BANKIMSINH MRW304P 20 239 MP PharmaceuticsNANO SUSPENSION/EMULSION,


DEVELOPMENT, EVALUATION AND OPTIMIZATION OF SOLID

LIPID NANOPARTICLE BASED GELMR. TULARAM BAROT 239

30-Nov-18 172390820004 CHIRAG NATUBHAI PATEL MRW304P 20 239 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


DESIGN AND CHARACTERIZATION OF TRANSDERMAL PATCH

OF VENLAFAXINE HYDROCHLORIDEDR. HITESH DALVADI 239

30-Nov-18 172390820005 HALPATI DARSHITA UMESH MRW304P 20 239 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DEVELOPMENT & OPTIMIZATION OF NANOPARTICLE BASE IN

SITU GEL OF LOTEPREDNOL ETABONATEDR. HITESH DALVADI 239

30-Nov-18 172390820006 OZA KIRTIBAHEN MANISHKUMAR MRW304P 20 239 MP PharmaceuticsNANO SUSPENSION/EMULSION,



NANOSUSPENSION FOR DISSOLUTION ENHANCEMENT OF

ZOTEPINE

DR. KOMAL PARMAR 239

30-Nov-18 172390820007 PATEL JENI RAMUBHAI MRW304P 20 239 MP Pharmaceutics MISCELANEOUSDEVELOPMENT, EVALUATION AND OPTIMIZATION OF ORAL

JELLYMR. TULARAM BAROT 239

30-Nov-18 172390820008 PATEL JIGNESHBHAI UTTAMBHAI MRW304P 20 239 MP PharmaceuticsNANO SUSPENSION/EMULSION,


FORMULATION AND DEVELOPMENT OF NOVEL BIGEL TOPICAL

DRUG DELIVERY OF LULICONAZOLEDR. KOMAL PARMAR 239

30-Nov-18 172390820009 Patel Kinjal Ishwarbhai MRW304P 20 239 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


DESIGN & OPTIMIZATION OF INTRANASAL DRUG DELIVERY OF

ANTIPSYCHOTIC DRUGDR. HITESH DALVADI 239

30-Nov-18 172390820010 SIDDIKI DOLLY SAFIULREHMAN MRW304P 20 239 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,



MICROEMULSION BASE HYDROGEL OF TOLNAFTATEDR. HITESH DALVADI 239

30-Nov-18 172390820011 SINGH PRAGATI SHESH MRW304P 20 239 MP Pharmaceutics MISCELANEOUSDESIGN & EVALUATION OF DRY POWDER INHALER FOR

PULMONARY DRUG DELIVERY SYSTEMDR. HITESH DALVADI 239

30-Nov-18 172390820012 SINGH SHOBHA DESHRAJ MRW304P 20 239 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND DEVELOPMENT OF IN-SITU GEL FOR

OCULAR DRUG DELIVERY OF TRAVOPROSTDR. KOMAL PARMAR 239

30-Nov-18 172390824001 BHANUSHALI PRIYA DEVJIBHAI MRW304P 24 239 MPPharmaceutical Quality


SPECTROSCOPIC AND CHROMATOGRAPHIC METHODS

DEVELOPMENT FOR SIMULTANEOUS ESTIMATION OF

CILNIDIPINE AND BISOPROLOL FUMARATE IN COMBINED

DOSAGE FORM

DR. ALISHA PATEL 239

30-Nov-18 172390824002 KAMLI ANKITA SHANTILAL MRW304P 24 239 MPPharmaceutical Quality



FOR SIMULTANEOUS ESTIMATION OF CANDESARTAN

CILEXETIL AND AMLODIPINE BESYLATE IN THEIR COMBINED

DOSAGE FORM

MADHURI HINGE 239

30-Nov-18 172390824003 KUMBHAR RIDDHI SHIVAJI MRW304P 24 239 MPPharmaceutical Quality


ANALYTICAL METHODS DEVELOPMENT & VALIDATION FOR

AMLODIPINE & CELECOXIB AND EVALUATION OF AN

ACTIVATED CARBON BASED DEACTIVATION SYSTEM FOR

DISPOSAL OF DIFFERENT MEDICATION

DR. ALISHA PATEL 239

30-Nov-18 172390824004 Madhumita Ghosh Chowdhury MRW304P 24 239 MPPharmaceutical Quality



FOR ESTIMATION OF LIFITEGRAST IN ITS PHARMACEUTICAL

DOSAGE FORM

MADHURI HINGE 239

30-Nov-18 172390824005 PATEL HETA AMRUTBHAI MRW304P 24 239 MPPharmaceutical Quality



SIMULTANEOUS ESTIMATION OF AMITRIPTYLINE

HYDROCHLORIDE AND PERPHENAZINE IN COMBINATION.

MRS. MEGHA ASHESH SHAH 239

30-Nov-18 172540820001 CHAUHAN RISHABH HEMANTKUMAR MRW304P 20 254 MP PharmaceuticsNANO SUSPENSION/EMULSION,


DEVELOPMENT AND EVALUATION OF GELATIN TREATED

ACECLOFENAC LOADED EUDRAGIT RS 100 NANOSUSPENSION

OF OSTEOARTHRITIS TREATMENT

DR. MANISH GOYANI 254

30-Nov-18 172540820002 Gangat Asma Abdulsattar MRW304P 20 254 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FABRICATION AND CHARACTERIZATION OF LULICONAZOLE

FILM-FORMING TOPICAL SPRAY FOR THE TREATMENT OF

FUNGAL INFECTION

DR. BHAVESH AKBARI 254

30-Nov-18 172540820003 VARADE SNEHALKUMARI MADHUKARBHAI MRW304P 20 254 MP Pharmaceutics OTHER (KINDLY SPECIFY)

PREPARATION AND CHARACTERIZATION OF SPHERICAL

AGGLOMERATES OF LORATADINE TO IMPROVE DISSOLUTION

RATE AND MICROMERITIC PROPERTIES

DR. BHAVESH AKBARI 254

30-Nov-18 172540824001 ANCY MATHEW MRW304P 24 254 MPPharmaceutical Quality


ANALYTICAL METHOD DEVELOPMENT AND ITS VALIDATION

FOR THE ESTIMATION OF VORTIOXETINE AND ARIPIPRAZOLE

IN COMBINATION.

DR. SURESH KUMAR 254

30-Nov-18 172540824002 Jangra Sandeepkumar Parasram MRW304P 24 254 MPPharmaceutical Quality



FOR THE ESTIMATION OF MIRABEGRON AND SOLIFENACIN

SUCCINATE IN COMBINATION.


30-Nov-18 172540824003 MAHIDA KAJAL RAKESHKUMAR MRW304P 24 254 MPPharmaceutical Quality


DEVELOPMENT AND VALIDATION OF ANALYTICALMETHOD

FOR THE ESTIMATION OF DOXOFYLLINE AND ERDOSTEINEIN

COMBINATION.


30-Nov-18 172540824004 Mandloi Nikita Rampalsingh MRW304P 24 254 MPPharmaceutical Quality


ANALYTICAL METHOD DEVELOPMENT AND ITS VALIDATION

FOR THE ESTIMATION OF TENELIGLIPTIN HYDROBROMIDE

HYDRATE AND GLIMEPIRIDE IN COMBINATION.


30-Nov-18 172540824005 PATEL HINAL HARISHBHAI MRW304P 24 254 MPPharmaceutical Quality



SIMULTANEOUS ESTIMATION OF PREGABALIN AND

MELOXICAM IN BINARY MIXTURE

MR. ROHAN BARSE 254

30-Nov-18 172540824006 VARACHHIYA HIRAL JASVANTSINH MRW304P 24 254 MPPharmaceutical Quality



FOR THE ESTIMATION OF ITOPRIDE HYDROCHLORIDE AND

OMEPRAZOLE IN COMBINATION.

MR. ROHAN BARSE 254

30-Nov-18 172650820001 BARIA ROHANKUMAR PANKAJKUMAR MRW304P 20 265 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,



MUCOADHESIVE BUCCAL DRUG DELIVERY OF

ANTICHOLINERGIC DRUG

MRS.ANKITA J.PATEL 265

30-Nov-18 172650820002 CHAUHAN JIGARKUMAR VIPULSINH MRW304P 20 265 MP Pharmaceutics MULTIPARTICULATEFORMULATION DEVELOPMENT AND EVALUATION OF

ESOMEPRAZOLE MICROSPONGES FOR GERDMR. AJAY TALELE 265

30-Nov-18 172650820003 HALPATI HEMANGINIBEN AMRUTBHAI MRW304P 20 265 MP PharmaceuticsNANO SUSPENSION/EMULSION,


FORMULATION AND EVALUATION OF AZELAIC ACID EMULGEL

FOR ACNE & HYPERPIGMENTATION TREATMENTMRS.ANKITA JAY PATEL 265

30-Nov-18 172650820004 Hiteshkumar Jitendra Tambekar MRW304P 20 265 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST



NANOPARTICLE CONTAINING RILPIVIRINEMR. AJAY TALELE 265

30-Nov-18 172650820005 KANZARIA JALPA HASMUKHBHAI MRW304P 20 265 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION DEVELOPMENT AND EVALUATION OF NASAL

IN SITU GEL OF ANTIEPILEPTIC DRUGDR. ANURADHA PRAJAPATI 265

30-Nov-18 172650820006 NAYAK ZEEL RUPESH MRW304P 20 265 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST



SUBLINGUAL TABLET OF LANSOPRAZOLEDR. KANTILAL NARKHEDE 265

30-Nov-18 172650820007 PATEL ARMY PRAKASHBHAI MRW304P 20 265 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST



SUBLINGUAL TABLET CONTAINING NISOLDIPINEDR.ANURADHA PRAJAPATI 265

30-Nov-18 172650820008 PATEL MANSVIBEN SURESHBHAI MRW304P 20 265 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION DEVELOPMENT AND EVALUATION OF REPEAT

ACTION DRUG DELIVERY SYSTEM OF LUBIPROSTONEMR. AJAY TALELE 265

30-Nov-18 172650820009 SURAJ KUMAR K CHOUDHARY MRW304P 20 265 MP Pharmaceutics OTHER (KINDLY SPECIFY)FORMULATION AND DEVELOPMENT OF NANOPARTICLE

CONTAINING VARDENAFIL FAST DISSOLVING TABLETDR. KANTILAL NARKHEDE 265

30-Nov-18 172650824001 BHADRA RINKALBEN MAHESHBHAI MRW304P 24 265 MPPharmaceutical Quality



FOR ESTIMATION OF PRIMIDONE IN K3EDTA HUMAN

PLASMA BY USING LC-ESI-MS/MS

DR.SHAILESH LUHAR 265

30-Nov-18 172650824002 DHUMAL SHRADDHA SURESH MRW304P 24 265 MPPharmaceutical Quality


DEVELOPMENT AND VALIDATION OF HPTLC METHOD FOR

SIMULTANEOUS ESTIMATION OF OFLOXACIN, CLOTRIMAZOLE

AND ORNIDAZOLE IN THEIR COMBINED DOSAGE FORM

DR. DULENDRA P. DAMAHE 265

30-Nov-18 172650824003 KHETIYA MEGHA MANOJBHAI MRW304P 24 265 MPPharmaceutical Quality



FOR ESTIMATION OF PAROXETINE HYDROCHLORIDE IN

K3EDTA HUMAN PLASMA BY USING LC-ESI-MS/MS

DR. SACHIN BHASKAR

NARKHEDE265

30-Nov-18 172650824006 PRAJAPATI HIRAL ARVINDBHAI MRW304P 24 265 MPPharmaceutical Quality



FOR ESTIMATION OF ATAZANAVIR IN K3EDTA HUMAN

PLASMA BY USING LC-ESI-MS/MS

DR. CHIRAG DESAI 265

30-Nov-18 172650824007 RATHOD SHEETAL JAGDISHCHANDRA MRW304P 24 265 MPPharmaceutical Quality



FOR ESTIMATION OF NINTEDANIB IN K3EDTA HUMAN

PLASMA BY USING LC-APCI-MS/MS

DR.SHAILESH LUHAR 265

30-Nov-18 172650824008 SINGH NEHA PRAMOD MRW304P 24 265 MPPharmaceutical Quality



SIMULTANEOUS ESTIMATION OF OFLOXACIN, ORNIDAZOLE

AND RACECADOTRIL IN PHARMACEUTICAL DOSAGE FORM BY

HPTLC

DR. DULENDRA P. DAMAHE 265

30-Nov-18 172680820001 PATEL MAYURKUMAR MAHESHBHAI MRW304P 20 268 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


DEVELOPMENT AND EVALUATION OF GASTRORETENTIVE

DRUG DELIVERY SYSTEM FOR LEVOSULPIRIDE.DR. JITENDRA SINGH YADAV 268

30-Nov-18 172680824001 PARMAR VIRANCHI JITENDRASINH MRW304P 24 268 MPPharmaceutical Quality



RP-HPLC METHOD FOR ESTIMATION OF VORTIOXRTINE

HYDROBROMIDE IN PHARMACEUTICAL DOSAGE FORM.

MR. SAGARKUMAR P. PATEL 268

01-Dec-18 172050825001 Himanshi Ravinder Kaul MRW304P 25 205 MP PharmacologyMETABOLIC DISORDER ( PLEASE

SPECIFY DISORDER)

EVALUATION OF ANTI-OBESITY ACTIVITY OF CORIANDRUM

SATIVUM IN RAT MODELDR. TEJAL R. GANDHI 205

01-Dec-18 172050825003 NAIR KARISHMA JAYPRAKASH MRW304P 25 205 MP PharmacologyMETABOLIC DISORDER ( PLEASE

SPECIFY DISORDER)

EVALUATION OF NOX-4 INHIBITOR -QUERCETIN IN 10 WEEKS

RAT MODEL OF DIABETIC NEPHROPATHYDR. TEJAL R. GANDHI 205

01-Dec-18 172050825004 PATEL ANJALIBEN BIPINBHAI MRW304P 25 205 MP Pharmacology RENAL DISORDERSEVALUATION OF SAPONIN RICH FRACTION OF FOLK

MEDICINES FOR THE TREATMENT OF KIDNEY STONE DISEASESDR. TEJAL R. GANDHI 205

01-Dec-18 172050825005 Patel Priyankaben Pankajbhai MRW304P 25 205 MP Pharmacology CVS DISORDER

CARDIOPROTECTIVE EFFECT OF FOENICULUM VULGARE IN

ISOPROTERENOL INDUCED MYOCARDIAL INFARCTION IN

EXPERIMENTAL RATS

DR. TEJAL R. GANDHI 205

01-Dec-18 172050825006 Prajapati Riddhi Bansilal MRW304P 25 205 MP Pharmacology RENAL DISORDERS

EVALUATION OF FLAVANOID RICH FRACTION OF FOLK

MEDICINES IN EXPERIMENTALLY INDUCED UROLITHIASIS IN

RAT MODEL


01-Dec-18 172050825007 PUROHIT MILAP DAKSHESHKUMAR MRW304P 25 205 MP Pharmacology CVS DISORDERCARDIOPROTECTIVE EFFECT OF LANSOPRAZOLE IN

EXPERIMENTALLY INDUCED CARDIAC FIBROSISDR. SARIKA JOHARI 205

01-Dec-18 172050825008 SINGH ANJALI JEEVANKUMAR MRW304P 25 205 MP Pharmacology CVS DISORDER

EFFECT OF SERCA2 CHANNEL MODULATOR ON DIABETIC

CARDIOYOPATHY IN RATSEFFECT OF SERCA2 CHANNEL

MODULATOR ON DIABETIC CARDIOYOPATHY IN RATS


01-Dec-18 172050825009 Vaibhav Hardikbhai Shah MRW304P 25 205 MP Pharmacology CVS DISORDER

PREPARATION AND EVALUATION OF POLYHERAL

FORMULATION FOR THE TREATMENT OF DIABETIC

CARDIOMYOPATHY


01-Dec-18 172120825001 GOHIL KIRAN KURJIBHAI MRW304P 25 212 MP Pharmacology OTHER (KINDLY SPECIFY)EVALUATION OF HAEMATINIC ACTIVITY OF ECLIPTA ALBA IN

PHENYL HYDRAZINE INDUCED ANEMIA IN RATSDR. RAVI A. MANEK 212

01-Dec-18 172120825002 GOL PRIYANKABEN RAMESHBHAI MRW304P 25 212 MP Pharmacology CNS DISORDEREVALATION OF ANTI PARKINSONIAN ACTIVITY OF

LANSOPRAZOLE IN ROTENONE INDUCED RAT MODELDR. DEVANG B. SHETH 212

01-Dec-18 172120825003 KUMBHANI MONIKA DHIRUBHAI MRW304P 25 212 MP PharmacologyG.I. TRACT ( PLEASE SPECIFY

DISORDER OR DISEASE)

EVALUATION OF THE EFFECT OF NELUMBO NUCIFERA PLANT

ON CHEMICAL INDUCED ULCERATIVE COLITIS IN RATSDR. JIGNESH I. PATEL 212

01-Dec-18 172120825004 MAHETAR NAFISA USMANBHAI MRW304P 25 212 MP PharmacologyRESPIRATORY DISORDER (

PLEASE SPECIFY DISORDER OR

EVALUATION OF EFFECT OF ETHANOLIC EXTRACT OF LEAVES

OF BOERHAAVIA DIFFUSA L. ON OVALBUMIN INDUCED LUNG

INFLAMMATION IN AN ANIMAL MODEL OF ASTHMA

DR. JIGNESH I. PATEL 212

01-Dec-18 172120825005 MATHUR ANMOL CHETENDRAKUMAR MRW304P 25 212 MP Pharmacology OTHER (KINDLY SPECIFY)

EVALUATION OF ANTI-ARTHRITIC POTENTIAL OF METHANOLIC

EXTRACT OF WHOLE PLANT OF BIOPHYTUM SENSITIVUMIN

FREUNDS ADJUVANT INDUCED ARTHRITIS IN RATS

DR. JIGNESH I. PATEL 212

01-Dec-18 172120825007 PATEL YASHIKAKUMARI ISHWARBHAI MRW304P 25 212 MP Pharmacology BABE STUDYBIOAVAILABILITY AND BIODISTRIBUTION STUDY OF RIFAXIMIN

CO-CRYSTALS IN RATSDR. RAVI A. MANEK 212

01-Dec-18 172120825008 VAGHASIYA TRUPTI PARSOTAMBHAI MRW304P 25 212 MP PharmacologyRESPIRATORY DISORDER (


EVALUATION OF EFFECT OF METHANOLIC EXTRACT OF

TERMINALIA CATAPPA L. IN EXPERIMENTAL ANIMAL MODEL

OF ASTHMA

DR. DEVANG B. SHETH 212

01-Dec-18 172120825009 VAGHELA UJJVAL PARESHBHAI MRW304P 25 212 MP Pharmacology OTHER (KINDLY SPECIFY)

EVALUATION OF EFFECT OF ETHANOLIC EXTRACT OF

PUERARIA TUBEROSA (WILLD.)DC. TUBERS IN LETROZOLE

INDUCED POLYCYSTIC OVARIAN SYNDROME (PCOS) IN RATS

DR. DEVANG B. SHETH 212

01-Dec-18 172130825001 KUNDU SMITA SUMANKUMAR MRW304P 25 213 MP Pharmacology CNS DISORDEREVALUATION OF ACTIVITY OF LOXOPROFEN IN VARIOUS

ANIMAL MODELS OF DEPRESSIONDR. DIGVIJAYSINH G. RANA 213

01-Dec-18 172130825002 MAYUR WANKHADE MRW304P 25 213 MP Pharmacology OTHER (KINDLY SPECIFY)INVESTIGATION OF NUTRACEUTICAL INTERVENTIONS IN

PACLITAXEL- INDUCED NEUROPATHIC PAINDR. DEEPTI K. JANI 213

01-Dec-18 172130825003 Mitra Pratik Sapan MRW304P 25 213 MP Pharmacology CNS DISORDEREVALUATION OF ACTIVITY OF TERIFLUNOMIDE IN VARIOUS


01-Dec-18 172130825004 NEMADE MRUNALI ASHOK MRW304P 25 213 MP Pharmacology BABE STUDY

COGNITION ASSESSMENT AMONG INDIAN PATIENTS WITH

HEAD AND NECK CANCER USING PROMIS AND ICCTF

RECOMMENDED TESTS

DR. DEEPTI K. JANI 213

01-Dec-18 172130825005 PANDEY RASHI SURESHKUMAR MRW304P 25 213 MP Pharmacology BABE STUDYBIOEQUIVALENCE STUDY OF FESOTERODINE FUMARATE

PROLONGED RELEASE TABLETS 8 MG IN FASTING CONDITIONSSANGEETHA L A RAJBANSHI 213

01-Dec-18 172130825006 PARMAR MOHINI DHARMENDRASINH MRW304P 25 213 MP Pharmacology BABE STUDYBIOEQUIVALENCE STUDY OF FESOTERODINE FUMARATE

PROLONGED RELEASE TABLETS 8 MG IN FED CONDITIONSSANGEETHA L.A. RAJBANSHI 213

01-Dec-18 172130825007 PATEL RUTU MANOJKUMAR MRW304P 25 213 MP Pharmacology CNS DISORDEREVALUATION OF ACTIVITY OF MONTELUKAST IN VARIOUS


29-Nov-18 172280822002 Donga Hiren Ashokbhai MRW304P 22 228 MP Pharmaceutical ChemistryMEDICINAL CHEMISTRY

(ANTICANCER)

NEW PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AS POTENTIAL

ANTICANCER AGENTS: DESIGN, SYNTHESIS AND BIOLOGICAL

EVALUATION


29-Nov-18 172280822005 Prajapati Ravi kumar Ghanshyambhai MRW304P 22 228 MP Pharmaceutical ChemistryMEDICINAL CHEMISTRY

(ANTICANCER)

DESIGN, SYNTHESIS AND EVALUATION OF SOME NEW

SUBSTITUTED PYRIMIDINE DERIVATIVES AS ANTICANCER

AGENTS


01-Dec-18 172280825001 BHOOMIT MAHENDRABHAI PATEL MRW304P 25 228 MP Pharmacology CANCEREFFECT OF DISULFIRAM AND CAFFEINE ON NSCLC RESISTANCE

TO GEMCITABINE AND CISPLATINDR. SUNITA GOSWAMI 228

01-Dec-18 172280825004 JAINEEL RAJESHBHAI DHAROD MRW304P 25 228 MP PharmacologyMETABOLIC DISORDER ( PLEASE

SPECIFY DISORDER)

EVALUATION OF ANTI-OBESITY EFFECT OF BUPROPION AND L-

HISTIDINE COMBINATION IN HFD INDUCED OBESITY IN MICEDR. GAURANG B. SHAH 228

01-Dec-18 172280825005 KINJALKUMARI SUMANBHAI GAMIT MRW304P 25 228 MP Pharmacology OTHER (KINDLY SPECIFY)FORMULATION OF PROBIOTIC CREAM AND ITS EVALUATION

IN DNFB INDUCED ATOPIC DERMATITIS IN MICEDR. GAURANG B. SHAH 228

01-Dec-18 172280825006 PURAV SUNILBHAI PATEL MRW304P 25 228 MP Pharmacology CVS DISORDEREVALUATE THE EFFECT OF TLR-4 ANTAGONIST IN

EXPERIMENTAL MODEL OF MYOCARDIAL INFARCTIONDR. ANITA A MEHTA 228

01-Dec-18 172280825007 Sangtani Kajol Haresh MRW304P 25 228 MP Pharmacology CNS DISORDER

ASSESSMENT OF THE RELATIONSHIP BETWEEN

ANTIDEPRESSANT AND COGNITION IMPROVING ABILITIES OF

SHANKHPUSHPI AND ASHWAGANDHA EXTRACTS IN MICE

DR. SUNITA GOSWAMI 228

01-Dec-18 172280825008 Suthar Hiran Nilesh MRW304P 25 228 MP Pharmacology CNS DISORDER

EVALUATION OF WITHANIA SOMNIFERA AND CONVOLVULUS

PLURICAULIS (CHOISY) IN SCHIZOPHRENIA INDUCED

IMPAIRMENTS IN VARIOUS COGNITIVE DOMAINS USING SUB-

CHRONIC PCP MODEL IN RATS

DR. GAURANG B. SHAH 228

01-Dec-18 172280825009 YADAV RUCHIBEN SHITALAPRASAD MRW304P 25 228 MP PharmacologyMETABOLIC DISORDER ( PLEASE

SPECIFY DISORDER)

EFFECT OF GENISTEIN ON OVARIAN FUNCTION IN

HYPOTHYRODISED RATDR. MUSTAKIM M. MANSURI 228

01-Dec-18 172390825001 RAJAWAT MAYANK PRAFUL MRW304P 25 239 MP PharmacologyRESPIRATORY DISORDER (


PHARMACOLOGICAL SCREENING OF ZEAL® SYRUP – A

POLYHERBAL FORMULATION FOR THE TREATMENT OF

COUGH.

MR. MITTAL DALAL 239

01-Dec-18 172390825002 SANAA ANSARI MRW304P 25 239 MP PharmacologyMETABOLIC DISORDER ( PLEASE

SPECIFY DISORDER)

EFFECT OF BAUHINIA PURPUREA AND ANETHUM

GRAVEOLENS ON EXPERIMENTALLY INDUCED POLYCYSTIC

OVARY SYNDROME IN RATS.

DR. ARINDAM PAUL 239

01-Dec-18 172390825003 SHAIKH UMAIRA ABDULRAKIB MRW304P 25 239 MP Pharmacology OTHER (KINDLY SPECIFY)

EFFECT OF TECOMELLA UNDULATAON EXPERIMENTALLY

INDUCED HEMOLYTIC ANEMIA AND ANTICOAGULANT

ACTIVITY IN RATS.

DR. ANKIT H MERAI 239

01-Dec-18 172390825004 TANDEL SHIVANI RAJESHBHAI MRW304P 25 239 MP Pharmacology EYE DISORDEREFFECT OF ISOTINE®, ISOTINE PLUS® AND ISOTINE GOLD® IN

EXPERIMENTAL MODELS OF CATARACT AND GLAUCOMA.DR. ARINDAM PAUL 239

01-Dec-18 172440825002 SHINDE AJAY PRAKASHBHAI MRW304P 25 244 MP Pharmacology CANCER

EVALUATION OF QUALITY OF LIFE AND ECONOMIC IMPACT IN

HEAD AND NECK CANCER PATIENTS UNDERGOING

RADIOTHERAPY WITH OR WITHOUT CONCURRENT

CHEMOTHERAPY AT A RURAL BASED CANCER CENTRE IN

INDIA.

DR. SAMIR SHAH 244

01-Dec-18 172450829001 Chaudhary Rajat b MRW304P 29 245 MP Clinical Pharmacy BABE STUDY

A RANDOMIZED DOUBLE BLINDED, CROSS-OVER

BIOEQUIVALENCE STUDY OF FELODIPINE EXTENDED RELEASE

(10 MG) TABLET UNDER FASTING CONDITION

DR. I. S. ANAND 245

01-Dec-18 172450829002 Chaudhary Shefali Jayantibhai MRW304P 29 245 MP Clinical Pharmacy OTHER (KINDLY SPECIFY)

ANTIBIOTIC SURVEY : PRESCRIBING PATTERN, INCIDENCE OF

SERIOUS ILLNESS AND TOTAL LENGTH OF STAY IN ICU

PATIENTS.

DR. I. S. ANAND 245

01-Dec-18 172450829003 Chaudhary Sumanben Rameshbhai MRW304P 29 245 MP Clinical Pharmacy BABE STUDY

A RANDOMIZED CROSS-OVER BIOEQUIVALENCE STUDY OF

METOPROLOL SUCCINATE EXTENDED RELEASE (200 MG)

TABLET UNDER FASTING CONDITION

DR. I. S. ANAND 245

01-Dec-18 172540825001 CHAUHAN VATSALSINH RAJENDRASINH MRW304P 25 254 MP Pharmacology CNS DISORDERpharmacological evaluation of Operculina turpethum root

extract in scopolamine-induced cognitive impairments in rats.DR. PALLAVI K.J 254

01-Dec-18 172540825003 PARMAR JANHAVI ANILKUMAR MRW304P 25 254 MP Pharmacology CNS DISORDER

pharmacological evaluation of Anti-inflammatory & Anti-

nociceptive activities of Doronicum hookeri root extract in

rats

DR. PALLAVI K.J 254

01-Dec-18 172540825004 SHAIKH ZEBABIBI ZAHIR MRW304P 25 254 MP Pharmacology CNS DISORDERpharmacological evaluation of Antidepressant activity of

Vigna radiata seed extract in rats.DR. PALLAVI K.J 254

01-Dec-18 172680825001 MISTRY SHIVANGIBEN NARESHKUMAR MRW304P 25 268 MP PharmacologyMETABOLIC DISORDER ( PLEASE

SPECIFY DISORDER)

EVALUATION OF ANTIDIABETIC POTENTIAL OF LUFFA

ECHINATA ROXB. IN DR. VIJAY LAMBOLE 268

01-Dec-18 172680825002 PARMAR POOJA SURESHCHANDRA MRW304P 25 268 MP Pharmacology OTHER (KINDLY SPECIFY)

EVALUATION OF ANTI-ARTHRITIC ACTIVITY OF BLUMEA

BALSAMIFERA (L.) DC. IN EXPERIMENTALLY INDUCED

ARTHRITIS IN RATS.

MR. VIPUL GAJERA 268

01-Dec-18 172680825003 PATEL PINESHKUMAR SURESHBHAI MRW304P 25 268 MP PharmacologyRESPIRATORY DISORDER (


EVALUATION OF ANTIASTHAMATIC ACTIVITY OF LUFFA

ECHINATA ROXB. FRUITS EXTRACTSMR. VIPUL GAJERA 268

01-Dec-18 172680825004 PATEL SHITALBEN RAJUBHAI MRW304P 25 268 MP PharmacologyG.I. TRACT ( PLEASE SPECIFY

DISORDER OR DISEASE)

EFFECT OF COMBINED EXTRACT OF CORDIA DICHOTOMA

FORST. AND AEGLE MARMELOS CORR. IN EXPERIMENTAL

MODELS OF GASTRIC ULCER

DR. VIJAY LAMBOLE 268

01-Dec-18 172820829002 MONA HITESHKUMAR SUTHAR MRW304P 29 282 MP Clinical Pharmacy OTHER (KINDLY SPECIFY)EVALUATION OF ANTIMICROBIAL AND ANTIDIARRHEAL FIX

DOSE COMBINATION AVAILABLE IN AN INDIAN MARKET.DR. HETAL D. SOLANKI 282

01-Dec-18 172820829003 PARMAR HEMAKSHIBEN RAMANBHAI MRW304P 29 282 MP Clinical Pharmacy OTHER (KINDLY SPECIFY)

KNOWLEDGE AND BEHAVIORAL PRACTICE OF ANTIBIOTIC

SELF-MEDICATION AMONG PHARMACY STUDENTS IN

GUJARAT

DR. HETAL D. SOLANKI 282

sd/-

I/C Contoller of Examination

gujarat technological university student list for …...pragnesh patani 206 26-nov-18 172080820001...

Documents